Structure of Nilotinib
CAS No.: 641571-10-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Nilotinib is an orally available inhibitor of Bcr-Abl tyrosine kinase with antineoplastic properties.
Synonyms: AMN107
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 641571-10-0 |
Formula : | C28H22F3N7O |
M.W : | 529.52 |
SMILES Code : | O=C(NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1)C3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3 |
Synonyms : |
AMN107
|
MDL No. : | MFCD09833716 |
InChI Key : | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem ID : | 644241 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
TXL-2 cells | 300 nM | 21 days | To evaluate the effect of nilotinib combined with AMD11070 on TXL-2 cells, the results showed that the combination treatment inhibited cell proliferation. | PMC3135709 |
Human valvular interstitial cells (VICs) | 10 μM | 24 h | Nilotinib increased calcification and BMP-2 expression in VICs. | PMC9544120 |
Human valvular interstitial cells (VICs) | 10 μM | 24 h | Nilotinib significantly inhibited autophagic activity and decreased VIC viability. | PMC9544120 |
Human Umbilical Vein Endothelial Cells (HUVEC) | 0.01-20 µM | 48 h | Nilotinib inhibited the growth and viability of HUVEC, whereas Imatinib showed no comparable effects. | PMC5669463 |
Human Coronary Artery Endothelial Cells (HCAEC) | 0.01-20 µM | 48 h | Nilotinib inhibited the growth and viability of HCAEC, whereas Imatinib showed no comparable effects. | PMC5669463 |
Human Microvascular Endothelial Cell Line (HMEC-1) | 0.01-20 µM | 48 h | Nilotinib inhibited the growth and viability of HMEC-1, whereas Imatinib showed no comparable effects. | PMC5669463 |
H295R cells | 1, 5, 10 µM | 72 h | Nilotinib alone or in combination with mitotane induced more significant cell viability inhibition in monolayer and spheroid preparations. | PMC5831608 |
ACC-T36 cells | 10 µM | 72 h | Nilotinib alone or in combination with mitotane induced more significant cell viability inhibition in monolayer and spheroid preparations. | PMC5831608 |
CD34+ hematopoietic stem cells | 3.6 µM | 15 days | To study the effect of Nilotinib on NK cell differentiation, results showed that Nilotinib inhibited the recovery of CD56+ cells. | PMC6207002 |
HCT116 | 20 μM | 24 h | Nilotinib significantly enhanced MHC-I expression in HCT116 cells. | PMC11325812 |
SW480 | 10 μM | 48 h | Nilotinib significantly enhanced MHC-I expression in SW480 cells. | PMC11325812 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mice | Bcr/Abl-positive ALL model | Oral | 75 mg/kg | Once daily for 12 days | To evaluate the effect of nilotinib combined with AMD11070 on the survival of Bcr/Abl-positive ALL mice, the results showed that the combination treatment significantly prolonged survival. | PMC3135709 |
Mice | Hyperlipidemic mouse model | Oral | 30 mg/kg | Once daily for 16 weeks | Nilotinib significantly increased aortic valve thickness in mice. | PMC9544120 |
Mice | ApoE-/- mice | Oral | 2x37.5 mg/kg | Twice daily for 8 weeks | Nilotinib promoted atherosclerosis in ApoE-/- mice, whereas Imatinib showed no comparable effects. | PMC5669463 |
Mice | BC CML mouse model | Oral gavage | 30 mg/kg | Once daily for 3 weeks | To evaluate the therapeutic effect of Nilotinib alone or in combination with M-miR-142 and PD-1 antibody in BC CML mouse models. The results showed that Nilotinib alone significantly reduced leukemic burden and prolonged survival, while the combination with M-miR-142 and PD-1 antibody ("triplet" therapy) further reduced leukemic burden and significantly extended survival. | PMC11787332 |
Mice | MC38 and CT26 tumor models | Oral | 25 mg/kg | Daily | The combination of nilotinib with anti-PDL1 antibody significantly inhibited tumor growth and enhanced CD8+ T cell cytotoxicity. | PMC11325812 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00785785 | - | Completed | - | - | |
NCT01220648 | Chronic Myeloid Leukemia | Phase 1 | Completed | - | Germany ... More >> Novartis Investigative Site Leipzig, Germany, 04103 Less << |
NCT01806571 | Untreated Adult Acute Myeloid ... More >>Leukemia Less << | Phase 2 | Active, not recruiting | April 18, 2020 | United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT00702403 | Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia Philadelphia Positive Adult Acute Lymphoblastic Leukemia Philadelphia Positive Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Relapsing Chronic Myelogenous Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << | Phase 1 Phase 2 | Completed | - | United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Florida H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium Tampa, Florida, United States, 33612 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT01110668 | Gastrointestinal Stromal Tumor | PHASE2 | COMPLETED | 2025-09-11 | Novartis Investigative Site, A... More >>dana, Turkey|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Istanbul, Turkey|Novartis Investigative Site, Izmir, Turkey Less << |
NCT00785785 | Gastrointestinal Stromal Tumor... More >> (GIST) Less << | Phase 3 | Completed | - | - |
NCT00441155 | Gastrointestinal Stromal Tumor... More >>s Less << | Phase 1 | Completed | - | United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less << |
NCT00702403 | - | Completed | - | - | |
NCT02174445 | Chronic Myeloid Leukemia | Phase 3 | Suspended(very slow recruitmen... More >>t rate and a lot of pat. didn't fulfil BCR-ABL requirements) Less << | June 2019 | Germany ... More >> Universitätsklinikum Aachen Aachen, Germany, 52074 Praxis Dr. Bruder / Dr. Heinrich / Prof. Bangerter Augsburg, Germany, 86150 Universitätsklinikum Bonn Bonn, Germany, 53105 Gemeinschaftspraxis Dresden, Germany, 01307 Praxis Dr. Hauch Erfurt, Germany, 99084 Internistische Schwerpunktpraxis Erlangen oncosearch Erlangen, Germany, 91052 Praxis für Hämatologie/Onkologie Dres. Rudolph, Sengpiel, von Verschuer Essen, Germany, 45136 University Medical Center Freiburg, Germany, 79106 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07747 Universitätsklinik Köln Köln, Germany, 50937 Gemeinschaftspraxis Hämatologie/Onkologie Magdeburg, Germany, 39104 Klinikum Mannheim GmbH Universitätsklinikum Mannheim, Germany, 68167 Überörtliche Gemeinschaftspraxis Hämato-Onkologie Pasing/Fürstenfeldbruck Munich, Germany, 81241 Klinikum rechts der Isar, Technische Universität München München, Germany, 81675 Onkologische Praxis Oldenburg Oldenburg, Germany, 26121 Medizinische Statistik Saarbrücken, GbR Saarbrucken, Germany, 66113 Universitätsklinikum Ulm Ulm, Germany, 89081 Less << |
NCT01294618 | Chronic Myelogenous Leukemia | Phase 2 | Completed | - | France ... More >> Hospices Civils de Lyon Lyon, France, 69003 Less << |
NCT01126892 | Chronic Myeloid Leukemia | PHASE3 | COMPLETED | 2025-04-11 | Hospital San José, Bogotá, Col... More >>ombia, Bogota, Colombia|Banco Municipal de Sangre, Caracas, Venezuela Less << |
NCT02627677 | Chronic Phase Chronic Myeloid ... More >>Leukemia Less << | Phase 3 | Active, not recruiting | December 31, 2022 | Belgium ... More >> Cliniques Universitaire Saint-Luc (Site 058) Bruxelles, Belgium, 1200 Less << |
NCT01289054 | - | Completed | - | United States, North Carolina ... More >> INC Research, LLC Wilmington, North Carolina, United States, 28405 Less << | |
NCT01279473 | Chronic Myelogenous Leukemia|A... More >>cute Lymphoblastic Leukemia Less << | PHASE1|PHASE2 | COMPLETED | - | Novartis Investigative Site, A... More >>ichi, Japan Less << |
NCT01077544 | Chronic Myeloid Leukemia|Acute... More >> Lymphoblastic Leukemia Less << | PHASE1 | COMPLETED | 2015-07-01 | Novartis Investigative Site, B... More >>ordeaux, Aquitaine, 33076, France|Novartis Investigative Site, Lille cedex, 59037, France|Novartis Investigative Site, Paris, 75571, France|Novartis Investigative Site, Poitiers, 86021, France|Novartis Investigative Site, Monza, MB, 20900, Italy|Novartis Investigative Site, Padova, PD, 35128, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CN, Netherlands|Novartis Investigative Site, West Midlands, Birmingham, B4 6NH, United Kingdom|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom|Novartis Investigative Site, Bristol, BS2 8BJ, United Kingdom Less << |
NCT00802841 | Chronic Myelogenous Leukemia | Phase 3 | Completed | - | - |
NCT00644878 | Chronic Myelogenous Leukemia -... More >> Chronic Phase Less << | PHASE2 | TERMINATED | 2025-03-12 | USC Norris Cancer Center Jane ... More >>Anne Nohl, Los Angeles, California, 90033, United States|Georgia Health Sciences University Dept. of MCG, Augusta, Georgia, 30912, United States|Indiana Blood and Marrow Institute, Beech Grove, Indiana, 46107, United States|University of Iowa Hospitals & Clinics Univ of Iowa Hosp & Clinic, Iowa City, Iowa, 52242, United States|LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center, New Orleans, Louisiana, 70115, United States|St. Agnes Hospital, Baltimore, Maryland, 21229, United States|Cancer Centers of the Carolinas, Greenville, South Carolina, 29615, United States|South Texas Institute of Cancer, Corpus Christi, Texas, 78405, United States|Baylor College of Medicine - Breast Care Dan L Duncan Cancer Ctr, Houston, Texas, 77030, United States|Central Utah Clinic Central Utah Clinic (7), Provo, Utah, 84604, United States|Froedert Memorial Lutheran Hospital Dept.ofFroedert Memorial, Milwaukee, Wisconsin, 53226, United States Less << |
NCT01077544 | Chronic Myeloid Leukemia|Acute... More >> Lymphoblastic Leukemia Less << | PHASE1 | COMPLETED | 2015-07-01 | Novartis Investigative Site, B... More >>ordeaux, Aquitaine, 33076, France|Novartis Investigative Site, Lille cedex, 59037, France|Novartis Investigative Site, Paris, 75571, France|Novartis Investigative Site, Poitiers, 86021, France|Novartis Investigative Site, Monza, MB, 20900, Italy|Novartis Investigative Site, Padova, PD, 35128, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CN, Netherlands|Novartis Investigative Site, West Midlands, Birmingham, B4 6NH, United Kingdom|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom|Novartis Investigative Site, Bristol, BS2 8BJ, United Kingdom Less << |
NCT01774630 | Leukemia, Myelogenous, Chronic... More >>, BCR-ABL Positive Less << | PHASE2 | COMPLETED | 2020-12-21 | CHU Angers, Angers, 49033, Fra... More >>nce|Institut Bergonié, Bordeaux, 33076, France|Centre Hospitalier de Versailles - H?pital André Mignot - Service de Médecine B, Le Chesnay, 78157, France|CHU de Nice, Service Hématologie Clinique, Nice, 06202, France|H?pital Haut Lévêque, Service Hématologie, Pessac, 33604, France|Centre Hospitalier Lyon Sud, Service Hématologie, Pierre Benite, 69495, France|CH d'Annecy, Pringy, 74374, France|H?pital Pontchaillou, Rennes, 35033, France|CHU de Toulouse, Service d'Hématologie, Toulouse, 31059, France|CH Valence, Valence, 26953, France Less << |
NCT00418769 | Healthy | PHASE1 | COMPLETED | - | - |
NCT00802841 | - | Completed | - | - | |
NCT01844765 | Leukemia Leuk... More >>emia,Pediatric Leukemia, Myleiod Leukemia, Mylegenous, Chronic Leukemia, Mylegenous, Accelerated BCR-ABL Positive Myeloproliferative Disorder Bone Marrow Disease Hematologic Diseases Neoplastic Processes Imatinib Dasatinib Enzyme Inhibitor Protein Kinase Inhibitor Less << | Phase 2 | Active, not recruiting | October 7, 2020 | - |
NCT01744665 | CML | Phase 2 | Active, not recruiting | February 1, 2021 | - |
NCT01368523 | Chronic Myelogenous Leukemia | Phase 4 | Completed | - | Poland ... More >> Novartis Investigative Site Gdansk, Poland Novartis Investigative Site Poznan, Poland Novartis Investigative Site Warsaw, Poland Less << |
NCT01168050 | Malignant Skin Melanoma T0|Sta... More >>ge III Melanoma|Stage IV Melanoma|Amplification Less << | PHASE2 | UNKNOWN | 2025-12-13 | H?pital Saint-Louis, Paris, 75... More >>010, France Less << |
NCT01535391 | Chronic Myeloid Leukemia | PHASE3 | COMPLETED | 2018-04-27 | Azienda Ospedaliera Nuovo Ospe... More >>dale "Torrette", Ancona, Italy|S.G. Moscati Hospital, Avellino, Italy|Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi, Bologna, 40138, Italy|USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia, Brescia, 25123, Italy|Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy|Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia, Catanzaro, Italy|Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna, Ferrara, Italy|Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria, Foggia, Italy|Clinica Ematologica - DiMI - Università degli Studi di Genova, Genova, Italy|Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino", Genova, Italy|U.O. di Ematologia- Ospedale dell'Angelo - Mestre, Mestre, Italy|U.O. Ematologia e Trapianto di MIdollo - Ist.Scientifico Ospedale San Raffaele, Milano, Italy|Centro Oncologico Modenese - Dipartimento di Oncoematologia, Modena, Italy|Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy|Ospedale Cervello, Palermo, 90146, Italy|Azienda Ospedaliera Universitaria - Policlinico Paolo Giaccone, Palermo, Italy|Div. di Ematologia di Muraglia -CTMO Ospedale San Salvatore, Pesaro, Italy|Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, Piacenza, Italy|Dipartimento Oncologico - Ospedale S.Maria delle Croci, Ravenna, Italy|Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova, Reggio Emilia, Italy|Ospedale "Infermi", Rimini, Italy|IRCCS Centro di riferimento Oncologico di Basilicata, Rionero in Vulture, Italy|Complesso Ospedaliero S. Giovanni Addolorata, Roma, Italy|Pronto Soccorso e Accettazione Ematologica - Dipartimento Biotecnologie Cellulari ed Ematologia - Università degli Studi di Roma "Sapienza", Roma, Italy|U.O.C. Ematologia Ospedale S. Eugenio, Roma, Italy|Università degli Studi Policlinico di Tor Vergata, Roma, Italy|Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte", Siena, Italy|U.O.C. di Ematolgia - A.O. " SS Annunziata" - P.O. S.G. Moscati, Taranto, Italy|SCDO Ematologia 2 AOU S.Giovanni Battista, Torino, Italy|Azienda USL 9 Treviso - U.O. di Ematologia, Treviso, 31100, Italy|Clinica Ematologica - Policlinico Universitario, Udine, Italy|Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi, Verona, Italy Less << |
NCT02709083 | Chronic Myelogenous Leukemia ... More >> Chronic Myeloid Leukemia Leukemia Less << | Phase 2 | Terminated(Original principal ... More >>investigator left institution) Less << | - | United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less << |
NCT02709083 | - | Terminated(Original principal ... More >>investigator left institution) Less << | - | - | |
NCT00418626 | Healthy | PHASE1 | COMPLETED | - | Richmond, Virginia, 23249, Uni... More >>ted States Less << |
NCT00418756 | Healthy | PHASE1 | COMPLETED | - | - |
NCT01289028 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE3 | COMPLETED | 2025-07-14 | Novartis Investigative Site, B... More >>ad Saarow, 155226, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40479, Germany|Novartis Investigative Site, Essen, 45122, Germany|Novartis Investigative Site, Frankfurt, 60488, Germany|Novartis Investigative Site, Freiburg, 79106, Germany|Novartis Investigative Site, Halle/'Saale, 06120, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Mannheim, 68167, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Muenchen, 81675, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Taormina, ME, 98039, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Padova, PD, 35100, Italy|Novartis Investigative Site, Aviano, PN, 33081, Italy|Novartis Investigative Site, Torino, TO, 10153, Italy Less << |
NCT01844765 | - | Active, not recruiting | - | - | |
NCT00750659 | Chronic Myeloid Leukemia|Acute... More >> Lymphoblastic Leukemia|Stem Cell Transplantation Less << | PHASE2 | COMPLETED | 2025-04-16 | Chaim Sheba Medical Center, Te... More >>l-Hashomer, 52621, Israel Less << |
NCT00129740 | Leukemia, Myelogenous, Chronic | PHASE2 | COMPLETED | 2018-07-11 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
NCT01140568 | Glioma | Phase 2 | Terminated(Sponsor contract wa... More >>s not renewed by mutual decision of sponsor and PI.) Less << | - | United States, California ... More >> The Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093 Less << |
NCT01289028 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE3 | COMPLETED | 2025-07-14 | Novartis Investigative Site, B... More >>ad Saarow, 155226, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40479, Germany|Novartis Investigative Site, Essen, 45122, Germany|Novartis Investigative Site, Frankfurt, 60488, Germany|Novartis Investigative Site, Freiburg, 79106, Germany|Novartis Investigative Site, Halle/'Saale, 06120, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Mannheim, 68167, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Muenchen, 81675, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Taormina, ME, 98039, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Padova, PD, 35100, Italy|Novartis Investigative Site, Aviano, PN, 33081, Italy|Novartis Investigative Site, Torino, TO, 10153, Italy Less << |
NCT01206088 | CML Nilotinib... More >> Imatinib Resistant Imatinib Intolerant Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> St. Mary hospital, Catholic medical center Seoul, Korea, Republic of Less << |
NCT02115386 | Philadelphia Positive (Ph+) Ch... More >>ronic Myeloid Leukemia Less << | PHASE3 | TERMINATED | 2016-10-31 | Novartis Investigative Site, M... More >>oscow, 125167, Russian Federation Less << |
NCT01261429 | Pigmented Villonodular Synovit... More >>is Less << | Phase 2 | Completed | - | France ... More >> Institut Bergonié Bordeaux, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France Hôpital La Timone Marseille, France Institut Paoli Calmettes Marseille, France Institut Curie Paris, France Institut Claudius Regaud Toulouse, France Institut Gustave Roussy Villejuif, France Italy Istituto Nazionale dei Tumori Milano, Italy Regina Elena National Cancer Institute Roma, Italy Netherlands Leiden University Medical Center Leiden, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Poland Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland United Kingdom University College Hospital UCL Hospitals NHS Foundation Trust London, United Kingdom Oxford Cancer Centre Oxford, United Kingdom Less << |
NCT00844298 | Leukemia | Phase 2 | Completed | - | Korea, Republic of ... More >> Daegu Fatima Hospital Daegu, Korea, Republic of, 701-600 Kyungpook National University Hospital Daegu, Korea, Republic of, 702-701 Yeungnam University Medical Center Daegu, Korea, Republic of, 712-749 Daegu Catholic University Hospital Daegu, Korea, Republic of National Cancer Center - Korea Goyang, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Jeollanam-do, Korea, Republic of, 519-809 Gyeongsang National University Hospital Jinju, Korea, Republic of, 660-701 Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Inje University Seoul Paik Hospital Seoul, Korea, Republic of, 100-032 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Kyung Hee University Hospital Seoul, Korea, Republic of, 130-702 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Ajou University Hospital Suwon, Korea, Republic of, 441-749 Ulsan University Hospital Ulsan, Korea, Republic of Less << |
NCT00844298 | - | Completed | - | - | |
NCT01155817 | Bone Marrow Transplant Failure... More >>|Lymphoma, Non-Hodgkin|Lymphoma, T-Cell, Peripheral Less << | PHASE1 | COMPLETED | 2025-12-13 | Stanford University School of ... More >>Medicine, Stanford, California, 94305, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, United States|Gordon and Leslie Diamond Health Care Centre Hematology Administration, Vancouver, British Columbia, V5Z1M9, Canada Less << |
NCT01657604 | Chronic Myeloid Leukemia | Phase 3 | Active, not recruiting | December 2022 | - |
NCT00751036 | Gastrointestinal Stromal Tumor... More >>s Less << | Phase 3 | Terminated | - | - |
NCT00633295 | Gastrointestinal Stromal Tumor... More >>s (GIST) Less << | Phase 2 | Completed | - | Israel ... More >> Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Tel Aviv, Israel Novartis Investigative Site Tel Hashomer, Israel Less << |
NCT02272777 | Leukemia | Phase 3 | Completed | - | China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 51000 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210008 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Fuzhou, China, 350001 Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200433 Less << |
NCT01254188 | Chronic Myeloid Leukemia | PHASE3 | COMPLETED | 2025-11-14 | Novartis Investigative Site, A... More >>lger, Bouzareah, 16000, Algeria|Novartis Investigative Site, Oran, 31000, Algeria|Novartis Investigative Site, Caba, Buenos Aires, C1221ADC, Argentina|Novartis Investigative Site, Paraná, Entre Rios, E3100BBJ, Argentina|Novartis Investigative Site, Buenos Aires, C1114AAN, Argentina|Novartis Investigative Site, Canberra, Australian Capital Territory, 2605, Australia|Novartis Investigative Site, Concord NSW, New South Wales, 2139, Australia|Novartis Investigative Site, Gosford, New South Wales, 2250, Australia|Novartis Investigative Site, Kingswood, New South Wales, 2747, Australia|Novartis Investigative Site, Kogarah, New South Wales, 2217, Australia|Novartis Investigative Site, Liverpool, New South Wales, 2170, Australia|Novartis Investigative Site, St. Leonards, New South Wales, 2065, Australia|Novartis Investigative Site, Westmead, New South Wales, 2145, Australia|Novartis Investigative Site, Douglas, Queensland, 4810, Australia|Novartis Investigative Site, Woolloongabba, Queensland, 4102, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Bedford Park, South Australia, 5042, Australia|Novartis Investigative Site, Hobart, Tasmania, 7000, Australia|Novartis Investigative Site, Box Hill, Victoria, 3128, Australia|Novartis Investigative Site, Clayton, Victoria, 3168, Australia|Novartis Investigative Site, Fitzroy, Victoria, 3065, Australia|Novartis Investigative Site, Heidelberg, Victoria, 3084, Australia|Novartis Investigative Site, Parkville, Victoria, 3050, Australia|Novartis Investigative Site, Wodonga, Victoria, 3690, Australia|Novartis Investigative Site, Nedlands, Western Australia, 6009, Australia|Novartis Investigative Site, Perth, Western Australia, 6000, Australia|Novartis Investigative Site, Salvador, BA, 41253-190, Brazil|Novartis Investigative Site, Goiania, GO, 74605-020, Brazil|Novartis Investigative Site, Curitiba, PR, 81520-060, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90430-091, Brazil|Novartis Investigative Site, Edmonton, Alberta, T6G 1Z2, Canada|Novartis Investigative Site, Vancouver, British Columbia, V5Z 1M9, Canada|Novartis Investigative Site, Vancouver, British Columbia, V6Z1Y6, Canada|Novartis Investigative Site, Moncton, New Brunswick, E1C 6Z8, Canada|Novartis Investigative Site, Saint John, New Brunswick, E2L 4L2, Canada|Novartis Investigative Site, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|Novartis Investigative Site, Halifax, Nova Scotia, B3H 1V7, Canada|Novartis Investigative Site, Barrie, Ontario, L4M 6M2, Canada|Novartis Investigative Site, Brampton, Ontario, L6R 3J7, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, London, Ontario, N6A 4G5, Canada|Novartis Investigative Site, Ottawa, Ontario, K1H 8L6, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Weston, Ontario, M9N 1N8, Canada|Novartis Investigative Site, Windsor, Ontario, N8W 2X3, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Québec, Quebec, G1J 1Z4, Canada|Novartis Investigative Site, Saskatoon, Saskatchewan, S7N 4H4, Canada|Novartis Investigative Site, Alexandria, 21131, Egypt|Novartis Investigative Site, Cairo, 11566, Egypt|Novartis Investigative Site, Cairo, Egypt|Novartis Investigative Site, Mansoura, 35516, Egypt|Novartis Investigative Site, Tamil Nadu, Chennai, 600035, India|Novartis Investigative Site, Pune, Maharashtra, 411004, India|Novartis Investigative Site, Vellore, Tamil Nadu, 632004, India|Novartis Investigative Site, Jerusalem, 9112001, Israel|Novartis Investigative Site, Petach Tikva, 49100, Israel|Novartis Investigative Site, Ramat Gan, 5266202, Israel|Novartis Investigative Site, Beirut, 166830, Lebanon|Novartis Investigative Site, Saida, 652, Lebanon|Novartis Investigative Site, Pulau Pinang, 10990, Malaysia|Novartis Investigative Site, Selangor, 68000, Malaysia|Novartis Investigative Site, Hermosillo, Sonora, 83000, Mexico|Novartis Investigative Site, San Luis Potosi, 78416, Mexico|Novartis Investigative Site, Muscat, 123, Oman|Novartis Investigative Site, Arkhangelsk, Russia, 163045, Russian Federation|Novartis Investigative Site, Novosibirsk, Russia, 630051, Russian Federation|Novartis Investigative Site, Perm, Russia, 614077, Russian Federation|Novartis Investigative Site, Ryazan, Russia, 390039, Russian Federation|Novartis Investigative Site, St Petersburg, Russia, 197341, Russian Federation|Novartis Investigative Site, Tumen, Russia, 625023, Russian Federation|Novartis Investigative Site, Ekaterinburg, 620137, Russian Federation|Novartis Investigative Site, Irkutsk, 664079, Russian Federation|Novartis Investigative Site, Moscow, 125167, Russian Federation|Novartis Investigative Site, Moscow, 125284, Russian Federation|Novartis Investigative Site, Nizhnii Novgorod, 603126, Russian Federation|Novartis Investigative Site, Rostov-on-Don, 344022, Russian Federation|Novartis Investigative Site, Rostov-on-Don, 344090, Russian Federation|Novartis Investigative Site, St Petersburg, 191024, Russian Federation|Novartis Investigative Site, St-Petersburg, 197022, Russian Federation|Novartis Investigative Site, Tula, 300053, Russian Federation|Novartis Investigative Site, Dammam, 15215, Saudi Arabia|Novartis Investigative Site, Jeddah, 21423, Saudi Arabia|Novartis Investigative Site, Jeddah, 21499, Saudi Arabia|Novartis Investigative Site, Riyadh, 11211, Saudi Arabia|Novartis Investigative Site, Riyadh, 11426, Saudi Arabia|Novartis Investigative Site, Soweto, Gauteng, 2013, South Africa|Novartis Investigative Site, Bloemfontein, 9301, South Africa|Novartis Investigative Site, Observatory, 7925, South Africa|Novartis Investigative Site, Parktown, 2193, South Africa|Novartis Investigative Site, Pretoria, 0002, South Africa|Novartis Investigative Site, Taipei, Taiwan, ROC, 112, Taiwan|Novartis Investigative Site, Lin-Kou, 33305, Taiwan|Novartis Investigative Site, Niaosong Township, 83301, Taiwan|Novartis Investigative Site, Taichung, 40447, Taiwan|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Muang, 40002, Thailand|Novartis Investigative Site, Sousse, Tunisie, 4000, Tunisia|Novartis Investigative Site, Tunis, 1008, Tunisia|Novartis Investigative Site, Dubai, United Arab Emirates Less << |
NCT01884922 | Refractory Low-grade Gliomas ... More >> Recurrent Low-grade Gliomas Less << | Phase 1 | Recruiting | May 2019 | Austria ... More >> Medical University of Vienna Not yet recruiting Vienna, Austria, A-1090 Contact: Amedeo AZIZI, MD amedeo.azizi@meduniwien.ac.at Principal Investigator: Amedeo AZIZI, MD Denmark Rigshospitalet Not yet recruiting Copenhagen, Denmark, DK - 2100 Contact: Karsten Nysom, MD-PhD 35 45 08 09 ext +45 karsten.nysom@regionh.dk Principal Investigator: Karsten Nysom, MD-PhD France Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Jacques GRILL, MD 0142116209 ext +33 jacques.grill@gustaveroussy.fr Contact: Rudiger HASSELBERG 0142116250 ext +33 rudiger.hasselberg@gustaveroussy.fr Principal Investigator: Jacques GRILL, MD Germany Koordinierungszentrum für Klinische Studien (KKS) der Charité Not yet recruiting Berlin, Germany, 13353 Contact: Pablo HERNAIZ-DRIEVER, MD pablo.hernaiz@charite.de Principal Investigator: Pablo HERNAIZ-DRIEVER, MD Italy University Hospital of Padua Not yet recruiting Padua, Italy, 35128 Contact: Enrico OPOCHER, MD eopocher@libero.it Principal Investigator: Enrico OPOCHER Netherlands Erasmus MC/Sophia Children's Hospital Not yet recruiting Rotterdam, Netherlands, 3015GJ Contact: IM van der Sluis, MD-PhD 10 703 6691 ext +31 i.vandersluis@erasmusmc.nl Principal Investigator: IM van der Sluis, MD-PhD Spain Fundació Sant Joan de Déu Not yet recruiting Esplugues del Llobregat (Barcelona), Spain, 08950 Contact: Ofelia Cruz, MD 93 253 21 14 ext +34 ocruz@hsjdbcn.org Principal Investigator: Ofelia Cruz, MD Switzerland Swiss Pediatric Oncology Group Not yet recruiting Bern, Switzerland, 3008 Contact: Nicolas Gerber, MD 44 266 31 17 ext +41 nicolas.gerber@kispi.uzh.ch Principal Investigator: Nicolas GERBER, MD United Kingdom Cancer Research UK Clinical Trials Unit School of Cancer Sciences University of Birmingham Not yet recruiting Edgbaston, Birmingham, United Kingdom, B15 2TT Contact: Susan PICTON, MD Susan.Picton@leedsth.nhs.uk Principal Investigator: Susan PICTON, MD Less << |
NCT01254188 | Chronic Myeloid Leukemia | PHASE3 | COMPLETED | 2025-11-14 | Novartis Investigative Site, A... More >>lger, Bouzareah, 16000, Algeria|Novartis Investigative Site, Oran, 31000, Algeria|Novartis Investigative Site, Caba, Buenos Aires, C1221ADC, Argentina|Novartis Investigative Site, Paraná, Entre Rios, E3100BBJ, Argentina|Novartis Investigative Site, Buenos Aires, C1114AAN, Argentina|Novartis Investigative Site, Canberra, Australian Capital Territory, 2605, Australia|Novartis Investigative Site, Concord NSW, New South Wales, 2139, Australia|Novartis Investigative Site, Gosford, New South Wales, 2250, Australia|Novartis Investigative Site, Kingswood, New South Wales, 2747, Australia|Novartis Investigative Site, Kogarah, New South Wales, 2217, Australia|Novartis Investigative Site, Liverpool, New South Wales, 2170, Australia|Novartis Investigative Site, St. Leonards, New South Wales, 2065, Australia|Novartis Investigative Site, Westmead, New South Wales, 2145, Australia|Novartis Investigative Site, Douglas, Queensland, 4810, Australia|Novartis Investigative Site, Woolloongabba, Queensland, 4102, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Bedford Park, South Australia, 5042, Australia|Novartis Investigative Site, Hobart, Tasmania, 7000, Australia|Novartis Investigative Site, Box Hill, Victoria, 3128, Australia|Novartis Investigative Site, Clayton, Victoria, 3168, Australia|Novartis Investigative Site, Fitzroy, Victoria, 3065, Australia|Novartis Investigative Site, Heidelberg, Victoria, 3084, Australia|Novartis Investigative Site, Parkville, Victoria, 3050, Australia|Novartis Investigative Site, Wodonga, Victoria, 3690, Australia|Novartis Investigative Site, Nedlands, Western Australia, 6009, Australia|Novartis Investigative Site, Perth, Western Australia, 6000, Australia|Novartis Investigative Site, Salvador, BA, 41253-190, Brazil|Novartis Investigative Site, Goiania, GO, 74605-020, Brazil|Novartis Investigative Site, Curitiba, PR, 81520-060, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90430-091, Brazil|Novartis Investigative Site, Edmonton, Alberta, T6G 1Z2, Canada|Novartis Investigative Site, Vancouver, British Columbia, V5Z 1M9, Canada|Novartis Investigative Site, Vancouver, British Columbia, V6Z1Y6, Canada|Novartis Investigative Site, Moncton, New Brunswick, E1C 6Z8, Canada|Novartis Investigative Site, Saint John, New Brunswick, E2L 4L2, Canada|Novartis Investigative Site, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|Novartis Investigative Site, Halifax, Nova Scotia, B3H 1V7, Canada|Novartis Investigative Site, Barrie, Ontario, L4M 6M2, Canada|Novartis Investigative Site, Brampton, Ontario, L6R 3J7, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, London, Ontario, N6A 4G5, Canada|Novartis Investigative Site, Ottawa, Ontario, K1H 8L6, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Weston, Ontario, M9N 1N8, Canada|Novartis Investigative Site, Windsor, Ontario, N8W 2X3, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Québec, Quebec, G1J 1Z4, Canada|Novartis Investigative Site, Saskatoon, Saskatchewan, S7N 4H4, Canada|Novartis Investigative Site, Alexandria, 21131, Egypt|Novartis Investigative Site, Cairo, 11566, Egypt|Novartis Investigative Site, Cairo, Egypt|Novartis Investigative Site, Mansoura, 35516, Egypt|Novartis Investigative Site, Tamil Nadu, Chennai, 600035, India|Novartis Investigative Site, Pune, Maharashtra, 411004, India|Novartis Investigative Site, Vellore, Tamil Nadu, 632004, India|Novartis Investigative Site, Jerusalem, 9112001, Israel|Novartis Investigative Site, Petach Tikva, 49100, Israel|Novartis Investigative Site, Ramat Gan, 5266202, Israel|Novartis Investigative Site, Beirut, 166830, Lebanon|Novartis Investigative Site, Saida, 652, Lebanon|Novartis Investigative Site, Pulau Pinang, 10990, Malaysia|Novartis Investigative Site, Selangor, 68000, Malaysia|Novartis Investigative Site, Hermosillo, Sonora, 83000, Mexico|Novartis Investigative Site, San Luis Potosi, 78416, Mexico|Novartis Investigative Site, Muscat, 123, Oman|Novartis Investigative Site, Arkhangelsk, Russia, 163045, Russian Federation|Novartis Investigative Site, Novosibirsk, Russia, 630051, Russian Federation|Novartis Investigative Site, Perm, Russia, 614077, Russian Federation|Novartis Investigative Site, Ryazan, Russia, 390039, Russian Federation|Novartis Investigative Site, St Petersburg, Russia, 197341, Russian Federation|Novartis Investigative Site, Tumen, Russia, 625023, Russian Federation|Novartis Investigative Site, Ekaterinburg, 620137, Russian Federation|Novartis Investigative Site, Irkutsk, 664079, Russian Federation|Novartis Investigative Site, Moscow, 125167, Russian Federation|Novartis Investigative Site, Moscow, 125284, Russian Federation|Novartis Investigative Site, Nizhnii Novgorod, 603126, Russian Federation|Novartis Investigative Site, Rostov-on-Don, 344022, Russian Federation|Novartis Investigative Site, Rostov-on-Don, 344090, Russian Federation|Novartis Investigative Site, St Petersburg, 191024, Russian Federation|Novartis Investigative Site, St-Petersburg, 197022, Russian Federation|Novartis Investigative Site, Tula, 300053, Russian Federation|Novartis Investigative Site, Dammam, 15215, Saudi Arabia|Novartis Investigative Site, Jeddah, 21423, Saudi Arabia|Novartis Investigative Site, Jeddah, 21499, Saudi Arabia|Novartis Investigative Site, Riyadh, 11211, Saudi Arabia|Novartis Investigative Site, Riyadh, 11426, Saudi Arabia|Novartis Investigative Site, Soweto, Gauteng, 2013, South Africa|Novartis Investigative Site, Bloemfontein, 9301, South Africa|Novartis Investigative Site, Observatory, 7925, South Africa|Novartis Investigative Site, Parktown, 2193, South Africa|Novartis Investigative Site, Pretoria, 0002, South Africa|Novartis Investigative Site, Taipei, Taiwan, ROC, 112, Taiwan|Novartis Investigative Site, Lin-Kou, 33305, Taiwan|Novartis Investigative Site, Niaosong Township, 83301, Taiwan|Novartis Investigative Site, Taichung, 40447, Taiwan|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Muang, 40002, Thailand|Novartis Investigative Site, Sousse, Tunisie, 4000, Tunisia|Novartis Investigative Site, Tunis, 1008, Tunisia|Novartis Investigative Site, Dubai, United Arab Emirates Less << |
NCT02353728 | Chronic Myeloid Leukemia | PHASE2 | COMPLETED | 2025-02-21 | Weill Cornell Medical College,... More >> New York, New York, 10065, United States Less << |
NCT02774512 | Colon Cancer | EARLY_PHASE1 | WITHDRAWN | 2025-11-17 | Institut Bergonié, Bordeaux, 3... More >>3076, France Less << |
NCT01735955 | Chronic Myelogenous Leukemia (... More >>CML)|Metastatic Gastrointestinal Stromal Tumors (GIST)|Acute Lymphoblastic Leukemia (ALL)|Receptor Tyrosine Kinase (KIT) Mutated Melanoma Less << | PHASE4 | COMPLETED | 2023-07-07 | Novartis Investigative Site, A... More >>lbany, New York, 12208, United States|Novartis Investigative Site, Houston, Texas, 77030, United States|Novartis Investigative Site, Vienna, A 1090, Austria|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Halifax, Nova Scotia, B3H 1V7, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, Toronto, Ontario, M5G1X5, Canada|Novartis Investigative Site, Lille, 59000, France|Novartis Investigative Site, Paris, 75571, France|Novartis Investigative Site, Hong Kong SAR, Hong Kong|Novartis Investigative Site, Budapest, 1062, Hungary|Novartis Investigative Site, Budapest, 1097, Hungary|Novartis Investigative Site, Haifa, 3109601, Israel|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Genova, GE, 16147, Italy|Novartis Investigative Site, Modena, MO, 41124, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Candiolo, TO, 10060, Italy|Novartis Investigative Site, Suwon, Gyeonggi-do, 443380, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 05505, Korea, Republic of|Novartis Investigative Site, Seoul, 06351, Korea, Republic of|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Leiden, 2300 RC, Netherlands|Novartis Investigative Site, Moscow, 117198, Russian Federation|Novartis Investigative Site, Singapore, 119228, Singapore|Novartis Investigative Site, Singapore, 169608, Singapore|Novartis Investigative Site, Bratislava, 833 10, Slovakia|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Malm?, SE-205 02, Sweden|Novartis Investigative Site, Cambridge, London, CB2 2QQ, United Kingdom|Novartis Investigative Site, London, SW3 6JJ, United Kingdom|Novartis Investigative Site, Manchester, M20 4BX, United Kingdom|Novartis Investigative Site, Newcastle upon Tyne, NE7 7DN, United Kingdom Less << |
NCT01179737 | Pulmonary Arterial Hypertensio... More >>n Less << | Phase 2 | Terminated(Study was terminate... More >>d due to serious adverse event (SAE)) Less << | - | United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02118 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, 48109-0391 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Ohio Novartis Investigative Site Cleveland, Ohio, United States, 44195 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37232-2573 Canada, Alberta Novartis Investigative Site Calgary, Alberta, Canada, T6G 2B7 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Marburg, Germany, 35039 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 120-752 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 168752 Switzerland Novartis Investigative Site Zurich, Switzerland, 8091 Less << |
NCT00756509 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE4 | COMPLETED | 2024-12-18 | Novartis Investigative Site, H... More >>elsinki, FIN-00029, Finland|Novartis Investigative Site, Lyon, 69373, France|Novartis Investigative Site, Bad Saarow, 15526, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Milano, MI, 20133, Italy Less << |
NCT00751036 | - | Terminated | - | - | |
NCT02225574 | Leukemia | Phase 1 | Terminated(Slow Accrual - Only... More >> 1 patient enrolled in Phase 1 - Study never went to Phase II) Less << | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00471328 | - | Completed | - | - | |
NCT00782834 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE2 | TERMINATED | 2025-10-09 | Fox Chase Cancer Center, Phila... More >>delphia, Pennsylvania, 19111, United States Less << |
NCT00782834 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE2 | TERMINATED | 2025-10-09 | Fox Chase Cancer Center, Phila... More >>delphia, Pennsylvania, 19111, United States Less << |
NCT00471328 | Gastrointestinal Stromal Tumor... More >>s Less << | Phase 3 | Completed | - | - |
NCT01061177 | CML in Chronic Phase | PHASE4 | COMPLETED | 2025-07-14 | Novartis Investigative Site, G... More >>raz, 8036, Austria|Novartis Investigative Site, Innsbruck, A-6020, Austria|Novartis Investigative Site, Linz, 4010, Austria|Novartis Investigative Site, Rankweil, A-6830, Austria|Novartis Investigative Site, Salzburg, 5020, Austria|Novartis Investigative Site, Vienna, A-1130, Austria|Novartis Investigative Site, Wels, A-4600, Austria|Novartis Investigative Site, Wien, A-1140, Austria|Novartis Investigative Site, Aalst, 9300, Belgium|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Brussels, BE-B-1200, Belgium|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Bruxelles, 1000, Belgium|Novartis Investigative Site, Bruxelles, 1070, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, Edegem, 2650, Belgium|Novartis Investigative Site, Gent, 9000, Belgium|Novartis Investigative Site, Hasselt, 3500, Belgium|Novartis Investigative Site, Laeken, 1020, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Luxembourg, 1210, Belgium|Novartis Investigative Site, Roeselare, 8800, Belgium|Novartis Investigative Site, Verviers, 4800, Belgium|Novartis Investigative Site, Yvoir, 5530, Belgium|Novartis Investigative Site, Pleven, 5800, Bulgaria|Novartis Investigative Site, Plovdiv, 4002, Bulgaria|Novartis Investigative Site, Sofia, 1431, Bulgaria|Novartis Investigative Site, Sofia, 1756, Bulgaria|Novartis Investigative Site, Varna, 9000, Bulgaria|Novartis Investigative Site, Rijeka, 51000, Croatia|Novartis Investigative Site, Zagreb, 10000, Croatia|Novartis Investigative Site, Olomouc, CZE, 775 20, Czech Republic|Novartis Investigative Site, Brno - Bohunice, 625 00, Czech Republic|Novartis Investigative Site, Hradec Kralove, 500 05, Czech Republic|Novartis Investigative Site, Praha 2, 128 20, Czech Republic|Novartis Investigative Site, Aarhus C, DK-8000, Denmark|Novartis Investigative Site, Copenhagen, DK-2100, Denmark|Novartis Investigative Site, Odense C, DK-5000, Denmark|Novartis Investigative Site, Tartu, 51006, Estonia|Novartis Investigative Site, HUS Helsinki, FIN-00029, Finland|Novartis Investigative Site, Oulu, 900114, Finland|Novartis Investigative Site, Bayonne, Bayonne cedex, 64109, France|Novartis Investigative Site, Paris Cedex 10, Cedex 10, 75475, France|Novartis Investigative Site, Saint Denis, FRANCE / La Reunion, 97405, France|Novartis Investigative Site, Monte-Carlo, Principauté de Monaco, 98012, France|Novartis Investigative Site, Aix en Provence Cedex 1, 13616, France|Novartis Investigative Site, Amiens cedex1, 80054, France|Novartis Investigative Site, Angers Cedex 1, 49033, France|Novartis Investigative Site, Argenteuil Cedex, 95107, France|Novartis Investigative Site, Avignon cedex 9, 84902, France|Novartis Investigative Site, Besancon cedex, 25030, France|Novartis Investigative Site, Blois Cedex, 41016, France|Novartis Investigative Site, Bordeaux, 33076, France|Novartis Investigative Site, Brest, 29200, France|Novartis Investigative Site, Caen, 14000, France|Novartis Investigative Site, Chalon sur Sa?ne, 71321, France|Novartis Investigative Site, Chambéry cedex, 73011, France|Novartis Investigative Site, Clermont-Ferrand cedex 1, 63003, France|Novartis Investigative Site, Compiègne cedex, 60321, France|Novartis Investigative Site, Corbeil Essonnes, 91100, France|Novartis Investigative Site, Creteil, 94010, France|Novartis Investigative Site, Dijon, 21034, France|Novartis Investigative Site, Dunkerque, 59240, France|Novartis Investigative Site, Grenoble, 38043, France|Novartis Investigative Site, La Roche sur Yon cedex 9, 85925, France|Novartis Investigative Site, Le Chesnay, 78157, France|Novartis Investigative Site, Le Coudray, 28630, France|Novartis Investigative Site, Le Mans Cedex 09, 72037, France|Novartis Investigative Site, Lens Cedex, 62307, France|Novartis Investigative Site, Lille cedex, 59020, France|Novartis Investigative Site, Limoges cedex, 87042, France|Novartis Investigative Site, Marseille cedex 20, 13915, France|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Metz Cedex 01, 57038, France|Novartis Investigative Site, Montfermeil, 93370, France|Novartis Investigative Site, Montpellier cedex 5, 34295, France|Novartis Investigative Site, Mulhouse cedex, 68070, France|Novartis Investigative Site, Macon Cedex, 71018, France|Novartis Investigative Site, Nantes, 44035, France|Novartis Investigative Site, Nice Cedex 2, 06189, France|Novartis Investigative Site, Nimes, 32900, France|Novartis Investigative Site, Paris, 75012, France|Novartis Investigative Site, Pau, 64000, France|Novartis Investigative Site, Perpignan, 66046, France|Novartis Investigative Site, Pringy cedex, 74374, France|Novartis Investigative Site, Reims, 51092, France|Novartis Investigative Site, Rennes, 35019, France|Novartis Investigative Site, Roubaix, 59100, France|Novartis Investigative Site, Rouen Cedex 1, 76038, France|Novartis Investigative Site, Saint Brieuc cedex 1, 22027, France|Novartis Investigative Site, Saint Priest en Jarez Cedex, 42271, France|Novartis Investigative Site, St Quentin Cedex, 02321, France|Novartis Investigative Site, Strasbourg cedex, 67085, France|Novartis Investigative Site, Strasbourg cedex, 67091, France|Novartis Investigative Site, Toulouse Cedex 9, 31059, France|Novartis Investigative Site, Tours Cedex 9, 37044, France|Novartis Investigative Site, Troyes, 10003, France|Novartis Investigative Site, Koeln, Nordrhein-Westfalen, 50937, Germany|Novartis Investigative Site, Aachen, 52074, Germany|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Augsburg, 86156, Germany|Novartis Investigative Site, Bamberg, 96049, Germany|Novartis Investigative Site, Bayreuth, 95445, Germany|Novartis Investigative Site, Berlin, 10707, Germany|Novartis Investigative Site, Berlin, 10709, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Berlin, 14195, Germany|Novartis Investigative Site, Bielefeld, 33604, Germany|Novartis Investigative Site, Bonn, 53105, Germany|Novartis Investigative Site, Bottrop, 46236, Germany|Novartis Investigative Site, Bremen, 28177, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Duisburg, 47166, Germany|Novartis Investigative Site, Eisenach, 99817, Germany|Novartis Investigative Site, Eschweiler, 52249, Germany|Novartis Investigative Site, Essen, 45136, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Frankfurt, Oder, 15236, Germany|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Frankfurt, 60596, Germany|Novartis Investigative Site, Freiburg, 79106, Germany|Novartis Investigative Site, Fulda, 36043, Germany|Novartis Investigative Site, Giessen, 35392, Germany|Novartis Investigative Site, Goslar, 38642, Germany|Novartis Investigative Site, Greifswald, 17475, Germany|Novartis Investigative Site, Hagen, 58097, Germany|Novartis Investigative Site, Hamburg, 20246, Germany|Novartis Investigative Site, Hamm, 59063, Germany|Novartis Investigative Site, Hannover, 30170, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Herrsching, 82211, Germany|Novartis Investigative Site, Hildesheim, 31134, Germany|Novartis Investigative Site, Jena, 07740, Germany|Novartis Investigative Site, Karlsruhe, 76133, Germany|Novartis Investigative Site, Karlsruhe, 76135, Germany|Novartis Investigative Site, Kassel, 34119, Germany|Novartis Investigative Site, Kassel, 34125, Germany|Novartis Investigative Site, Kiel, 24116, Germany|Novartis Investigative Site, Koblenz, 56068, Germany|Novartis Investigative Site, Landshut, 84028, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Lemgo, 32657, Germany|Novartis Investigative Site, Luebeck, 23563, Germany|Novartis Investigative Site, Magdeburg, 39104, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Mannheim, 68169, Germany|Novartis Investigative Site, Marburg, 35039, Germany|Novartis Investigative Site, Moers, 47441, Germany|Novartis Investigative Site, Muelheim, 45468, Germany|Novartis Investigative Site, Muenchen, 80335, Germany|Novartis Investigative Site, Muenchen, 81241, Germany|Novartis Investigative Site, Muenchen, 81737, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Mutlangen, 73557, Germany|Novartis Investigative Site, M?nchengladbach, 41063, Germany|Novartis Investigative Site, München, 81675, Germany|Novartis Investigative Site, Neunkirchen, 66538, Germany|Novartis Investigative Site, Nuernberg, 90419, Germany|Novartis Investigative Site, Nuernberg, 90449, Germany|Novartis Investigative Site, Offenburg, 77652, Germany|Novartis Investigative Site, Paderborn, 33102, Germany|Novartis Investigative Site, Ravensburg, 88214, Germany|Novartis Investigative Site, Rostock, 18057, Germany|Novartis Investigative Site, Schorndorf, 73614, Germany|Novartis Investigative Site, Schw?bisch-Hall, 74523, Germany|Novartis Investigative Site, Sindelfingen, 71065, Germany|Novartis Investigative Site, Stuttgart, 70376, Germany|Novartis Investigative Site, Traunstein, 83278, Germany|Novartis Investigative Site, Triberg, 78098, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Velbert, 42551, Germany|Novartis Investigative Site, Viersen, 45468, Germany|Novartis Investigative Site, Weilheim, 82362, Germany|Novartis Investigative Site, Wendlingen, 73240, Germany|Novartis Investigative Site, Wuerzburg, 97080, Germany|Novartis Investigative Site, Würzburg, 97080, Germany|Novartis Investigative Site, Zella-Mehlis, 98544, Germany|Novartis Investigative Site, Alexandroupolis, Evros, 68100, Greece|Novartis Investigative Site, Athens, GR, 115 27, Greece|Novartis Investigative Site, Larissa, GR, 411 10, Greece|Novartis Investigative Site, Thessaloniki, GR, 546 42, Greece|Novartis Investigative Site, Athens, 11527, Greece|Novartis Investigative Site, Heraklion Crete, 711 10, Greece|Novartis Investigative Site, Patras, 265 00, Greece|Novartis Investigative Site, Budapest, 1097, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Kaposvar, 7400, Hungary|Novartis Investigative Site, Pecs, 7624, Hungary|Novartis Investigative Site, Szeged, H-6725, Hungary|Novartis Investigative Site, Ancona, AN, 60126, Italy|Novartis Investigative Site, Avellino, AV, 83100, Italy|Novartis Investigative Site, Bari, BA, 70124, Italy|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Brindisi, BR, 72100, Italy|Novartis Investigative Site, Brescia, BS, 25123, Italy|Novartis Investigative Site, Cagliari, CA, 09121, Italy|Novartis Investigative Site, Cagliari, CA, 09126, Italy|Novartis Investigative Site, Cuneo, CN, 12100, Italy|Novartis Investigative Site, Rossano, CS, 87067, Italy|Novartis Investigative Site, Catanzaro, CZ, 88100, Italy|Novartis Investigative Site, Cona, FE, 44100, Italy|Novartis Investigative Site, San Giovanni Rotondo, FG, 71013, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Roma, Lazio, 00168, Italy|Novartis Investigative Site, Lecce, LE, 73100, Italy|Novartis Investigative Site, Livorno, LI, 57124, Italy|Novartis Investigative Site, Milano, MI, 20122, Italy|Novartis Investigative Site, Milano, MI, 20162, Italy|Novartis Investigative Site, Modena, MO, 41100, Italy|Novartis Investigative Site, Nuoro, NU, 08100, Italy|Novartis Investigative Site, Palermo, PA, 90146, Italy|Novartis Investigative Site, Padova, PD, 35128, Italy|Novartis Investigative Site, Pescara, PE, 65124, Italy|Novartis Investigative Site, Pisa, PI, 56126, Italy|Novartis Investigative Site, Pesaro, PU, 61100, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Potenza, PZ, 85100, Italy|Novartis Investigative Site, Ravenna, RA, 48100, Italy|Novartis Investigative Site, Reggio Calabria, RC, 89124, Italy|Novartis Investigative Site, Reggio Emilia, RE, 42123, Italy|Novartis Investigative Site, Roma, RM, 00144, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Nocera Inferiore, SA, 84014, Italy|Novartis Investigative Site, Siena, SI, 53100, Italy|Novartis Investigative Site, Sassari, SS, 07100, Italy|Novartis Investigative Site, Taranto, TA, 74100, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Torino, TO, 10126, Italy|Novartis Investigative Site, Terni, TR, 05100, Italy|Novartis Investigative Site, Treviso, TV, 31100, Italy|Novartis Investigative Site, Ronciglione, VT, 01100, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Napoli, 80132, Italy|Novartis Investigative Site, Novara, 28100, Italy|Novartis Investigative Site, Perugia, 06129, Italy|Novartis Investigative Site, Riga, LV, 1006, Latvia|Novartis Investigative Site, Kaunas, 3007, Lithuania|Novartis Investigative Site, Klaipeda, LT-92231, Lithuania|Novartis Investigative Site, Vilnius, LT-08661, Lithuania|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Delft, 2625 AD, Netherlands|Novartis Investigative Site, Enschede, 7513 ER, Netherlands|Novartis Investigative Site, Groningen, 9713 GZ, Netherlands|Novartis Investigative Site, Nijmegen, 6525 GA, Netherlands|Novartis Investigative Site, Rotterdam, 3075 EA, Netherlands|Novartis Investigative Site, Zwolle, 8025 AB, Netherlands|Novartis Investigative Site, Bergen, NO-5021, Norway|Novartis Investigative Site, Oslo, NO-0310, Norway|Novartis Investigative Site, Stavanger, 4068, Norway|Novartis Investigative Site, Tromsoe, NO-9038, Norway|Novartis Investigative Site, Trondheim, 7006, Norway|Novartis Investigative Site, Gdansk, 80-952, Poland|Novartis Investigative Site, Krakow, 30-510, Poland|Novartis Investigative Site, Lublin, 20-081, Poland|Novartis Investigative Site, Warsaw, 02-106, Poland|Novartis Investigative Site, Warszawa, 02-776, Poland|Novartis Investigative Site, Wroclaw, 50-367, Poland|Novartis Investigative Site, Lisboa, 1150-314, Portugal|Novartis Investigative Site, Porto, 4200-072, Portugal|Novartis Investigative Site, Porto, 4200319, Portugal|Novartis Investigative Site, Bucharest, District 2, 022328, Romania|Novartis Investigative Site, Iasi, Jud. Iasi, 700111, Romania|Novartis Investigative Site, Bucharest, 030171, Romania|Novartis Investigative Site, Bucharest, 050098, Romania|Novartis Investigative Site, Cluj-Napoca, 3400, Romania|Novartis Investigative Site, Timisoara, 300 079, Romania|Novartis Investigative Site, Kosice, Slovak Republic, 04066, Slovakia|Novartis Investigative Site, Bratislava, 851 07, Slovakia|Novartis Investigative Site, Martin, 03601, Slovakia|Novartis Investigative Site, Celje, 3000, Slovenia|Novartis Investigative Site, Ljubljana, 1000, Slovenia|Novartis Investigative Site, Elche, Alicante, 03203, Spain|Novartis Investigative Site, Oviedo, Asturias, 33006, Spain|Novartis Investigative Site, Santander, Cantabria, 39008, Spain|Novartis Investigative Site, Toledo, Castilla la Mancha, 45071, Spain|Novartis Investigative Site, Salamanca, Castilla y Leon, 37007, Spain|Novartis Investigative Site, Badalona, Catalunya, 08916, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Tarragona, Catalunya, 43005, Spain|Novartis Investigative Site, Terrassa, Catalunya, 08221, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46010, Spain|Novartis Investigative Site, La Coruna, Galicia, 15006, Spain|Novartis Investigative Site, Orense, Galicia, 32005, Spain|Novartis Investigative Site, Las Palmas de Gran Canaria, Las Palmas de G.C, 35010, Spain|Novartis Investigative Site, Majadahonda, Madrid, 28222, Spain|Novartis Investigative Site, Pamplona, Navarra, 31008, Spain|Novartis Investigative Site, Bilbao, Pais Vasco, 48013, Spain|Novartis Investigative Site, San Sebastian, Pais Vasco, 20080, Spain|Novartis Investigative Site, La Laguna, Santa Cruz de Tenerife, 38320, Spain|Novartis Investigative Site, Baracaldo, Vizcaya, 48903, Spain|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Madrid, 28006, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Murcia, 30008, Spain|Novartis Investigative Site, Zaragoza, 50009, Spain|Novartis Investigative Site, G?teborg, SE-413 45, Sweden|Novartis Investigative Site, Huddinge, SE-14186, Sweden|Novartis Investigative Site, Link?ping, SE-581 85, Sweden|Novartis Investigative Site, Lulea, SE-971 80, Sweden|Novartis Investigative Site, Lund, SE-221 85, Sweden|Novartis Investigative Site, Stockholm, SE-171 76, Sweden|Novartis Investigative Site, Ume?, SE-901 85, Sweden|Novartis Investigative Site, Uppsala, SE-751 85, Sweden|Novartis Investigative Site, Bern, 3010, Switzerland|Novartis Investigative Site, Chur, 7000, Switzerland|Novartis Investigative Site, Genève, 1211, Switzerland|Novartis Investigative Site, Zurich, 8091, Switzerland|Novartis Investigative Site, Uxbridge, London, UB8 3NN, United Kingdom|Novartis Investigative Site, Cardiff, CF14 4XW, United Kingdom|Novartis Investigative Site, Dudley, DY1 2HQ, United Kingdom|Novartis Investigative Site, London, SE5 9RS, United Kingdom|Novartis Investigative Site, London, W12 0HS, United Kingdom|Novartis Investigative Site, Nottingham, NG5, United Kingdom|Novartis Investigative Site, Oxford, OX3 7LJ, United Kingdom Less << |
NCT01179737 | - | Terminated(Study was terminate... More >>d due to serious adverse event (SAE)) Less << | - | - | |
NCT02001818 | Chronic Myeloid Leukaemia | Phase 2 | Recruiting | December 2021 | Australia, South Australia ... More >> Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Tim Hughes, MBBS, MD,FRACP, FRCPA +61 8 822 3330 timothy.hughes@health.sa.gov.au Principal Investigator: Tim Hughes, MBBS, MD, FRACP, FRCPA Less << |
NCT03228303 | Chronic Myeloid Leukemia | Early Phase 1 | Not yet recruiting | August 1, 2020 | - |
NCT01061177 | CML in Chronic Phase | PHASE4 | COMPLETED | 2025-07-14 | Novartis Investigative Site, G... More >>raz, 8036, Austria|Novartis Investigative Site, Innsbruck, A-6020, Austria|Novartis Investigative Site, Linz, 4010, Austria|Novartis Investigative Site, Rankweil, A-6830, Austria|Novartis Investigative Site, Salzburg, 5020, Austria|Novartis Investigative Site, Vienna, A-1130, Austria|Novartis Investigative Site, Wels, A-4600, Austria|Novartis Investigative Site, Wien, A-1140, Austria|Novartis Investigative Site, Aalst, 9300, Belgium|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Brussels, BE-B-1200, Belgium|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Bruxelles, 1000, Belgium|Novartis Investigative Site, Bruxelles, 1070, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, Edegem, 2650, Belgium|Novartis Investigative Site, Gent, 9000, Belgium|Novartis Investigative Site, Hasselt, 3500, Belgium|Novartis Investigative Site, Laeken, 1020, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Luxembourg, 1210, Belgium|Novartis Investigative Site, Roeselare, 8800, Belgium|Novartis Investigative Site, Verviers, 4800, Belgium|Novartis Investigative Site, Yvoir, 5530, Belgium|Novartis Investigative Site, Pleven, 5800, Bulgaria|Novartis Investigative Site, Plovdiv, 4002, Bulgaria|Novartis Investigative Site, Sofia, 1431, Bulgaria|Novartis Investigative Site, Sofia, 1756, Bulgaria|Novartis Investigative Site, Varna, 9000, Bulgaria|Novartis Investigative Site, Rijeka, 51000, Croatia|Novartis Investigative Site, Zagreb, 10000, Croatia|Novartis Investigative Site, Olomouc, CZE, 775 20, Czech Republic|Novartis Investigative Site, Brno - Bohunice, 625 00, Czech Republic|Novartis Investigative Site, Hradec Kralove, 500 05, Czech Republic|Novartis Investigative Site, Praha 2, 128 20, Czech Republic|Novartis Investigative Site, Aarhus C, DK-8000, Denmark|Novartis Investigative Site, Copenhagen, DK-2100, Denmark|Novartis Investigative Site, Odense C, DK-5000, Denmark|Novartis Investigative Site, Tartu, 51006, Estonia|Novartis Investigative Site, HUS Helsinki, FIN-00029, Finland|Novartis Investigative Site, Oulu, 900114, Finland|Novartis Investigative Site, Bayonne, Bayonne cedex, 64109, France|Novartis Investigative Site, Paris Cedex 10, Cedex 10, 75475, France|Novartis Investigative Site, Saint Denis, FRANCE / La Reunion, 97405, France|Novartis Investigative Site, Monte-Carlo, Principauté de Monaco, 98012, France|Novartis Investigative Site, Aix en Provence Cedex 1, 13616, France|Novartis Investigative Site, Amiens cedex1, 80054, France|Novartis Investigative Site, Angers Cedex 1, 49033, France|Novartis Investigative Site, Argenteuil Cedex, 95107, France|Novartis Investigative Site, Avignon cedex 9, 84902, France|Novartis Investigative Site, Besancon cedex, 25030, France|Novartis Investigative Site, Blois Cedex, 41016, France|Novartis Investigative Site, Bordeaux, 33076, France|Novartis Investigative Site, Brest, 29200, France|Novartis Investigative Site, Caen, 14000, France|Novartis Investigative Site, Chalon sur Sa?ne, 71321, France|Novartis Investigative Site, Chambéry cedex, 73011, France|Novartis Investigative Site, Clermont-Ferrand cedex 1, 63003, France|Novartis Investigative Site, Compiègne cedex, 60321, France|Novartis Investigative Site, Corbeil Essonnes, 91100, France|Novartis Investigative Site, Creteil, 94010, France|Novartis Investigative Site, Dijon, 21034, France|Novartis Investigative Site, Dunkerque, 59240, France|Novartis Investigative Site, Grenoble, 38043, France|Novartis Investigative Site, La Roche sur Yon cedex 9, 85925, France|Novartis Investigative Site, Le Chesnay, 78157, France|Novartis Investigative Site, Le Coudray, 28630, France|Novartis Investigative Site, Le Mans Cedex 09, 72037, France|Novartis Investigative Site, Lens Cedex, 62307, France|Novartis Investigative Site, Lille cedex, 59020, France|Novartis Investigative Site, Limoges cedex, 87042, France|Novartis Investigative Site, Marseille cedex 20, 13915, France|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Metz Cedex 01, 57038, France|Novartis Investigative Site, Montfermeil, 93370, France|Novartis Investigative Site, Montpellier cedex 5, 34295, France|Novartis Investigative Site, Mulhouse cedex, 68070, France|Novartis Investigative Site, Macon Cedex, 71018, France|Novartis Investigative Site, Nantes, 44035, France|Novartis Investigative Site, Nice Cedex 2, 06189, France|Novartis Investigative Site, Nimes, 32900, France|Novartis Investigative Site, Paris, 75012, France|Novartis Investigative Site, Pau, 64000, France|Novartis Investigative Site, Perpignan, 66046, France|Novartis Investigative Site, Pringy cedex, 74374, France|Novartis Investigative Site, Reims, 51092, France|Novartis Investigative Site, Rennes, 35019, France|Novartis Investigative Site, Roubaix, 59100, France|Novartis Investigative Site, Rouen Cedex 1, 76038, France|Novartis Investigative Site, Saint Brieuc cedex 1, 22027, France|Novartis Investigative Site, Saint Priest en Jarez Cedex, 42271, France|Novartis Investigative Site, St Quentin Cedex, 02321, France|Novartis Investigative Site, Strasbourg cedex, 67085, France|Novartis Investigative Site, Strasbourg cedex, 67091, France|Novartis Investigative Site, Toulouse Cedex 9, 31059, France|Novartis Investigative Site, Tours Cedex 9, 37044, France|Novartis Investigative Site, Troyes, 10003, France|Novartis Investigative Site, Koeln, Nordrhein-Westfalen, 50937, Germany|Novartis Investigative Site, Aachen, 52074, Germany|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Augsburg, 86156, Germany|Novartis Investigative Site, Bamberg, 96049, Germany|Novartis Investigative Site, Bayreuth, 95445, Germany|Novartis Investigative Site, Berlin, 10707, Germany|Novartis Investigative Site, Berlin, 10709, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Berlin, 14195, Germany|Novartis Investigative Site, Bielefeld, 33604, Germany|Novartis Investigative Site, Bonn, 53105, Germany|Novartis Investigative Site, Bottrop, 46236, Germany|Novartis Investigative Site, Bremen, 28177, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Duisburg, 47166, Germany|Novartis Investigative Site, Eisenach, 99817, Germany|Novartis Investigative Site, Eschweiler, 52249, Germany|Novartis Investigative Site, Essen, 45136, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Frankfurt, Oder, 15236, Germany|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Frankfurt, 60596, Germany|Novartis Investigative Site, Freiburg, 79106, Germany|Novartis Investigative Site, Fulda, 36043, Germany|Novartis Investigative Site, Giessen, 35392, Germany|Novartis Investigative Site, Goslar, 38642, Germany|Novartis Investigative Site, Greifswald, 17475, Germany|Novartis Investigative Site, Hagen, 58097, Germany|Novartis Investigative Site, Hamburg, 20246, Germany|Novartis Investigative Site, Hamm, 59063, Germany|Novartis Investigative Site, Hannover, 30170, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Herrsching, 82211, Germany|Novartis Investigative Site, Hildesheim, 31134, Germany|Novartis Investigative Site, Jena, 07740, Germany|Novartis Investigative Site, Karlsruhe, 76133, Germany|Novartis Investigative Site, Karlsruhe, 76135, Germany|Novartis Investigative Site, Kassel, 34119, Germany|Novartis Investigative Site, Kassel, 34125, Germany|Novartis Investigative Site, Kiel, 24116, Germany|Novartis Investigative Site, Koblenz, 56068, Germany|Novartis Investigative Site, Landshut, 84028, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Lemgo, 32657, Germany|Novartis Investigative Site, Luebeck, 23563, Germany|Novartis Investigative Site, Magdeburg, 39104, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Mannheim, 68169, Germany|Novartis Investigative Site, Marburg, 35039, Germany|Novartis Investigative Site, Moers, 47441, Germany|Novartis Investigative Site, Muelheim, 45468, Germany|Novartis Investigative Site, Muenchen, 80335, Germany|Novartis Investigative Site, Muenchen, 81241, Germany|Novartis Investigative Site, Muenchen, 81737, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Mutlangen, 73557, Germany|Novartis Investigative Site, M?nchengladbach, 41063, Germany|Novartis Investigative Site, München, 81675, Germany|Novartis Investigative Site, Neunkirchen, 66538, Germany|Novartis Investigative Site, Nuernberg, 90419, Germany|Novartis Investigative Site, Nuernberg, 90449, Germany|Novartis Investigative Site, Offenburg, 77652, Germany|Novartis Investigative Site, Paderborn, 33102, Germany|Novartis Investigative Site, Ravensburg, 88214, Germany|Novartis Investigative Site, Rostock, 18057, Germany|Novartis Investigative Site, Schorndorf, 73614, Germany|Novartis Investigative Site, Schw?bisch-Hall, 74523, Germany|Novartis Investigative Site, Sindelfingen, 71065, Germany|Novartis Investigative Site, Stuttgart, 70376, Germany|Novartis Investigative Site, Traunstein, 83278, Germany|Novartis Investigative Site, Triberg, 78098, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Velbert, 42551, Germany|Novartis Investigative Site, Viersen, 45468, Germany|Novartis Investigative Site, Weilheim, 82362, Germany|Novartis Investigative Site, Wendlingen, 73240, Germany|Novartis Investigative Site, Wuerzburg, 97080, Germany|Novartis Investigative Site, Würzburg, 97080, Germany|Novartis Investigative Site, Zella-Mehlis, 98544, Germany|Novartis Investigative Site, Alexandroupolis, Evros, 68100, Greece|Novartis Investigative Site, Athens, GR, 115 27, Greece|Novartis Investigative Site, Larissa, GR, 411 10, Greece|Novartis Investigative Site, Thessaloniki, GR, 546 42, Greece|Novartis Investigative Site, Athens, 11527, Greece|Novartis Investigative Site, Heraklion Crete, 711 10, Greece|Novartis Investigative Site, Patras, 265 00, Greece|Novartis Investigative Site, Budapest, 1097, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Kaposvar, 7400, Hungary|Novartis Investigative Site, Pecs, 7624, Hungary|Novartis Investigative Site, Szeged, H-6725, Hungary|Novartis Investigative Site, Ancona, AN, 60126, Italy|Novartis Investigative Site, Avellino, AV, 83100, Italy|Novartis Investigative Site, Bari, BA, 70124, Italy|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Brindisi, BR, 72100, Italy|Novartis Investigative Site, Brescia, BS, 25123, Italy|Novartis Investigative Site, Cagliari, CA, 09121, Italy|Novartis Investigative Site, Cagliari, CA, 09126, Italy|Novartis Investigative Site, Cuneo, CN, 12100, Italy|Novartis Investigative Site, Rossano, CS, 87067, Italy|Novartis Investigative Site, Catanzaro, CZ, 88100, Italy|Novartis Investigative Site, Cona, FE, 44100, Italy|Novartis Investigative Site, San Giovanni Rotondo, FG, 71013, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Roma, Lazio, 00168, Italy|Novartis Investigative Site, Lecce, LE, 73100, Italy|Novartis Investigative Site, Livorno, LI, 57124, Italy|Novartis Investigative Site, Milano, MI, 20122, Italy|Novartis Investigative Site, Milano, MI, 20162, Italy|Novartis Investigative Site, Modena, MO, 41100, Italy|Novartis Investigative Site, Nuoro, NU, 08100, Italy|Novartis Investigative Site, Palermo, PA, 90146, Italy|Novartis Investigative Site, Padova, PD, 35128, Italy|Novartis Investigative Site, Pescara, PE, 65124, Italy|Novartis Investigative Site, Pisa, PI, 56126, Italy|Novartis Investigative Site, Pesaro, PU, 61100, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Potenza, PZ, 85100, Italy|Novartis Investigative Site, Ravenna, RA, 48100, Italy|Novartis Investigative Site, Reggio Calabria, RC, 89124, Italy|Novartis Investigative Site, Reggio Emilia, RE, 42123, Italy|Novartis Investigative Site, Roma, RM, 00144, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Nocera Inferiore, SA, 84014, Italy|Novartis Investigative Site, Siena, SI, 53100, Italy|Novartis Investigative Site, Sassari, SS, 07100, Italy|Novartis Investigative Site, Taranto, TA, 74100, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Torino, TO, 10126, Italy|Novartis Investigative Site, Terni, TR, 05100, Italy|Novartis Investigative Site, Treviso, TV, 31100, Italy|Novartis Investigative Site, Ronciglione, VT, 01100, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Napoli, 80132, Italy|Novartis Investigative Site, Novara, 28100, Italy|Novartis Investigative Site, Perugia, 06129, Italy|Novartis Investigative Site, Riga, LV, 1006, Latvia|Novartis Investigative Site, Kaunas, 3007, Lithuania|Novartis Investigative Site, Klaipeda, LT-92231, Lithuania|Novartis Investigative Site, Vilnius, LT-08661, Lithuania|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Delft, 2625 AD, Netherlands|Novartis Investigative Site, Enschede, 7513 ER, Netherlands|Novartis Investigative Site, Groningen, 9713 GZ, Netherlands|Novartis Investigative Site, Nijmegen, 6525 GA, Netherlands|Novartis Investigative Site, Rotterdam, 3075 EA, Netherlands|Novartis Investigative Site, Zwolle, 8025 AB, Netherlands|Novartis Investigative Site, Bergen, NO-5021, Norway|Novartis Investigative Site, Oslo, NO-0310, Norway|Novartis Investigative Site, Stavanger, 4068, Norway|Novartis Investigative Site, Tromsoe, NO-9038, Norway|Novartis Investigative Site, Trondheim, 7006, Norway|Novartis Investigative Site, Gdansk, 80-952, Poland|Novartis Investigative Site, Krakow, 30-510, Poland|Novartis Investigative Site, Lublin, 20-081, Poland|Novartis Investigative Site, Warsaw, 02-106, Poland|Novartis Investigative Site, Warszawa, 02-776, Poland|Novartis Investigative Site, Wroclaw, 50-367, Poland|Novartis Investigative Site, Lisboa, 1150-314, Portugal|Novartis Investigative Site, Porto, 4200-072, Portugal|Novartis Investigative Site, Porto, 4200319, Portugal|Novartis Investigative Site, Bucharest, District 2, 022328, Romania|Novartis Investigative Site, Iasi, Jud. Iasi, 700111, Romania|Novartis Investigative Site, Bucharest, 030171, Romania|Novartis Investigative Site, Bucharest, 050098, Romania|Novartis Investigative Site, Cluj-Napoca, 3400, Romania|Novartis Investigative Site, Timisoara, 300 079, Romania|Novartis Investigative Site, Kosice, Slovak Republic, 04066, Slovakia|Novartis Investigative Site, Bratislava, 851 07, Slovakia|Novartis Investigative Site, Martin, 03601, Slovakia|Novartis Investigative Site, Celje, 3000, Slovenia|Novartis Investigative Site, Ljubljana, 1000, Slovenia|Novartis Investigative Site, Elche, Alicante, 03203, Spain|Novartis Investigative Site, Oviedo, Asturias, 33006, Spain|Novartis Investigative Site, Santander, Cantabria, 39008, Spain|Novartis Investigative Site, Toledo, Castilla la Mancha, 45071, Spain|Novartis Investigative Site, Salamanca, Castilla y Leon, 37007, Spain|Novartis Investigative Site, Badalona, Catalunya, 08916, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Tarragona, Catalunya, 43005, Spain|Novartis Investigative Site, Terrassa, Catalunya, 08221, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46010, Spain|Novartis Investigative Site, La Coruna, Galicia, 15006, Spain|Novartis Investigative Site, Orense, Galicia, 32005, Spain|Novartis Investigative Site, Las Palmas de Gran Canaria, Las Palmas de G.C, 35010, Spain|Novartis Investigative Site, Majadahonda, Madrid, 28222, Spain|Novartis Investigative Site, Pamplona, Navarra, 31008, Spain|Novartis Investigative Site, Bilbao, Pais Vasco, 48013, Spain|Novartis Investigative Site, San Sebastian, Pais Vasco, 20080, Spain|Novartis Investigative Site, La Laguna, Santa Cruz de Tenerife, 38320, Spain|Novartis Investigative Site, Baracaldo, Vizcaya, 48903, Spain|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Madrid, 28006, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Murcia, 30008, Spain|Novartis Investigative Site, Zaragoza, 50009, Spain|Novartis Investigative Site, G?teborg, SE-413 45, Sweden|Novartis Investigative Site, Huddinge, SE-14186, Sweden|Novartis Investigative Site, Link?ping, SE-581 85, Sweden|Novartis Investigative Site, Lulea, SE-971 80, Sweden|Novartis Investigative Site, Lund, SE-221 85, Sweden|Novartis Investigative Site, Stockholm, SE-171 76, Sweden|Novartis Investigative Site, Ume?, SE-901 85, Sweden|Novartis Investigative Site, Uppsala, SE-751 85, Sweden|Novartis Investigative Site, Bern, 3010, Switzerland|Novartis Investigative Site, Chur, 7000, Switzerland|Novartis Investigative Site, Genève, 1211, Switzerland|Novartis Investigative Site, Zurich, 8091, Switzerland|Novartis Investigative Site, Uxbridge, London, UB8 3NN, United Kingdom|Novartis Investigative Site, Cardiff, CF14 4XW, United Kingdom|Novartis Investigative Site, Dudley, DY1 2HQ, United Kingdom|Novartis Investigative Site, London, SE5 9RS, United Kingdom|Novartis Investigative Site, London, W12 0HS, United Kingdom|Novartis Investigative Site, Nottingham, NG5, United Kingdom|Novartis Investigative Site, Oxford, OX3 7LJ, United Kingdom Less << |
NCT01099514 | Metastatic Melanoma With KIT A... More >>berration Less << | PHASE2 | COMPLETED | 2025-06-15 | Samsung Cancer Center, Seoul, ... More >>Korea, Republic of Less << |
NCT01043874 | Philadelphia Chromosome Positi... More >>ve|Chronic Myelogenous Leukemia in Chronic Phase Less << | PHASE4 | COMPLETED | 2025-01-14 | Novartis Investigative Site, N... More >>agoya-city, Aichi, 453-8511, Japan|Novartis Investigative Site, Nagoya-city, Aichi, 466-8560, Japan|Novartis Investigative Site, Nagoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Fukuoka-city, Fukuoka, 812-8582, Japan|Novartis Investigative Site, Kitakyushu, Fukuoka, 807-8556, Japan|Novartis Investigative Site, Hiroshima-city, Hiroshima, 734-8551, Japan|Novartis Investigative Site, Kumamoto City, Kumamoto, 860-8556, Japan|Novartis Investigative Site, Sendai-city, Miyagi, 983-8520, Japan|Novartis Investigative Site, Nagasaki-city, Nagasaki, 852-8501, Japan|Novartis Investigative Site, Okayama-city, Okayama, 700-8558, Japan|Novartis Investigative Site, Osaka-city, Osaka, 545-8586, Japan|Novartis Investigative Site, OsakaSayama, Osaka, 589-8511, Japan|Novartis Investigative Site, Suita-city, Osaka, 565-0871, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, 113-8519, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, 113-8655, Japan|Novartis Investigative Site, Shinjuku-ku, Tokyo, 160-0023, Japan|Novartis Investigative Site, Aomori, 030-8553, Japan|Novartis Investigative Site, Gifu, 501-1194, Japan|Novartis Investigative Site, Kyoto, 602-8566, Japan|Novartis Investigative Site, Saga, 849-8501, Japan Less << |
NCT01407198 | Chordoma | Phase 1 | Active, not recruiting | December 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less << |
NCT01223898 | Chronic Myeloid Leukemia | Phase 1 | Completed | - | Germany ... More >> Novartis Investigative Site Frankfurt/M, Germany, 60590 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Ulm, Germany, 89081 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G12 0YN Less << |
NCT01605981 | Chronic Myeloid Leukemia (CML) | PHASE4 | WITHDRAWN | 2025-01-17 | Novartis Investigative Site, F... More >>ortaleza, CE, 60115-290, Brazil|Novartis Investigative Site, Goiania, GO, 74605-020, Brazil|Novartis Investigative Site, Belo Horizonte, MG, 30130-100, Brazil|Novartis Investigative Site, Cuiaba, MS, 033426-102, Brazil|Novartis Investigative Site, Porto Alegre, Porto Alegre-RS, Brazil|Novartis Investigative Site, Curitiba, PR, 80060-900, Brazil|Novartis Investigative Site, Niterói, RJ, 24030210, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20.211-030, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90035-903, Brazil|Novartis Investigative Site, S?o José, Sao Paulo, 15015-110, Brazil|Novartis Investigative Site, Florianopolis, SC, 88034-000, Brazil|Novartis Investigative Site, Campinas, SP, 13083-970, Brazil|Novartis Investigative Site, Jaú, SP, 17210-080, Brazil|Novartis Investigative Site, Santo Andre, SP, 09190-615, Brazil|Novartis Investigative Site, Santos, SP, 11075-350, Brazil|Novartis Investigative Site, S?o Paulo, SP, 05651-901, Brazil|Novartis Investigative Site, S?o Paulo, SP, 08270-070, Brazil|Novartis Investigative Site, Sao Paulo, 03454-000, Brazil Less << |
NCT01166139 | Systemic Sclerosis | Phase 2 | Completed | - | United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 Less << |
NCT01166139 | - | Completed | - | - | |
NCT01252017 | Patients Who Have Received All... More >>o-HSCT Less << | Phase 2 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less << |
NCT01275586 | - | Completed | - | - | |
NCT01866553 | Chronic Myeloid Leukemia | Phase 2 | Terminated(insufficient enroll... More >>ment) Less << | - | Denmark ... More >> Aarhus University Hospital Aarhus, Denmark Finland Helsinki University Hospital Helsinki, Finland Netherlands VU University Medical Center Amsterdam, Netherlands Norway Trondheim University Hospital Trondheim, Norway Sweden Uppsala University Hospital Uppsala, Sweden Less << |
NCT01043874 | Philadelphia Chromosome Positi... More >>ve|Chronic Myelogenous Leukemia in Chronic Phase Less << | PHASE4 | COMPLETED | 2025-01-14 | Novartis Investigative Site, N... More >>agoya-city, Aichi, 453-8511, Japan|Novartis Investigative Site, Nagoya-city, Aichi, 466-8560, Japan|Novartis Investigative Site, Nagoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Fukuoka-city, Fukuoka, 812-8582, Japan|Novartis Investigative Site, Kitakyushu, Fukuoka, 807-8556, Japan|Novartis Investigative Site, Hiroshima-city, Hiroshima, 734-8551, Japan|Novartis Investigative Site, Kumamoto City, Kumamoto, 860-8556, Japan|Novartis Investigative Site, Sendai-city, Miyagi, 983-8520, Japan|Novartis Investigative Site, Nagasaki-city, Nagasaki, 852-8501, Japan|Novartis Investigative Site, Okayama-city, Okayama, 700-8558, Japan|Novartis Investigative Site, Osaka-city, Osaka, 545-8586, Japan|Novartis Investigative Site, OsakaSayama, Osaka, 589-8511, Japan|Novartis Investigative Site, Suita-city, Osaka, 565-0871, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, 113-8519, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, 113-8655, Japan|Novartis Investigative Site, Shinjuku-ku, Tokyo, 160-0023, Japan|Novartis Investigative Site, Aomori, 030-8553, Japan|Novartis Investigative Site, Gifu, 501-1194, Japan|Novartis Investigative Site, Kyoto, 602-8566, Japan|Novartis Investigative Site, Saga, 849-8501, Japan Less << |
NCT01400074 | Chronic Myeloid Leukemia | Phase 3 | Unknown | June 2014 | Korea, Republic of ... More >> Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Less << |
NCT01275586 | Neurofibromatosis ... More >> NF1 Neurofibromas Less << | Early Phase 1 | Completed | - | United States, Indiana ... More >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less << |
NCT00788775 | Mucosal Lentiginous Melanoma|A... More >>cral Melanoma|Melanoma Less << | PHASE2 | COMPLETED | 2025-03-14 | The Angeles Clinic and Researc... More >>h Institute, Santa Monica, California, 90404, United States|University of Colorado, Aurora, Colorado, 80045, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States Less << |
NCT03079505 | Chronic Myeloid Leukemia - Chr... More >>onic Phase Less << | Phase 3 | Recruiting | August 2022 | Qatar ... More >> National Center for Cancer Care & Research (NCCCR) Recruiting Doha, Qatar, 3050 Contact: Mohamed Yassin Contact: Abdulqadir Nashwan 0097466473549 anashwan@hamad.qa Less << |
NCT02546674 | Chronic Myeloid Leukemia | PHASE4 | COMPLETED | 2021-03-25 | Novartis Investigative Site, M... More >>annheim, Baden-Wuerttemberg, 68305, Germany|Novartis Investigative Site, Herne, Nordrhein-Westfalen, 44625, Germany|Novartis Investigative Site, Luebeck, Schleswig-holstein, 23563, Germany|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Augsburg, 86179, Germany|Novartis Investigative Site, Bad Mergentheim, 97980, Germany|Novartis Investigative Site, Bad Reichenhall, 83435, Germany|Novartis Investigative Site, Bad Saarow, 15526, Germany|Novartis Investigative Site, Bad Soden, 65812, Germany|Novartis Investigative Site, Bamberg, 96049, Germany|Novartis Investigative Site, Bayreuth, 95445, Germany|Novartis Investigative Site, Berlin, 12351, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Berlin, 13357, Germany|Novartis Investigative Site, Berlin, 13581, Germany|Novartis Investigative Site, Berlin, 14195, Germany|Novartis Investigative Site, Biberach, 88400, Germany|Novartis Investigative Site, Bremerhaven, 27568, Germany|Novartis Investigative Site, Chemnitz, 09113, Germany|Novartis Investigative Site, Donauwoerth, 86609, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Duesseldorf, 40479, Germany|Novartis Investigative Site, Erfurt, 99085, Germany|Novartis Investigative Site, Essen, 45136, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Georgsmarienhuette, 49124, Germany|Novartis Investigative Site, Giessen, 35392, Germany|Novartis Investigative Site, Goslar, 38642, Germany|Novartis Investigative Site, G?ppingen, 73035, Germany|Novartis Investigative Site, Halberstadt, 38820, Germany|Novartis Investigative Site, Halle S, 06120, Germany|Novartis Investigative Site, Halle, 06110, Germany|Novartis Investigative Site, Hannover, 30161, Germany|Novartis Investigative Site, Hannover, 30170, Germany|Novartis Investigative Site, Heidelberg, 69115, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Jena, 07740, Germany|Novartis Investigative Site, Kassel, 34125, Germany|Novartis Investigative Site, Kiel, 24105, Germany|Novartis Investigative Site, Koeln, 50671, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Magdeburg, 39104, Germany|Novartis Investigative Site, Memmingen, 87700, Germany|Novartis Investigative Site, Minden, 32429, Germany|Novartis Investigative Site, Moers, 47441, Germany|Novartis Investigative Site, Muelheim, 45468, Germany|Novartis Investigative Site, Muenchen, 80335, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Mutlangen, 73557, Germany|Novartis Investigative Site, Nuernberg, 90403, Germany|Novartis Investigative Site, Nuernberg, 90419, Germany|Novartis Investigative Site, Oldenburg, 26121, Germany|Novartis Investigative Site, Paderborn, 33098, Germany|Novartis Investigative Site, Passau, 94036, Germany|Novartis Investigative Site, Potsdam, 14467, Germany|Novartis Investigative Site, Rostock, 18059, Germany|Novartis Investigative Site, Rotenburg, 27356, Germany|Novartis Investigative Site, Saarbruecken, 66113, Germany|Novartis Investigative Site, Schorndorf, 73614, Germany|Novartis Investigative Site, Schweinfurt, 97422, Germany|Novartis Investigative Site, Schw?bisch-Hall, 74523, Germany|Novartis Investigative Site, Tübingen, 72076, Germany|Novartis Investigative Site, Velbert, 42551, Germany|Novartis Investigative Site, Westerstede, 26655, Germany|Novartis Investigative Site, Wiesbaden, 65191, Germany|Novartis Investigative Site, Wilhelmshaven, 26389, Germany|Novartis Investigative Site, Wolfsburg, 38440, Germany|Novartis Investigative Site, Worms, 67547, Germany|Novartis Investigative Site, Wuerzburg, 97080, Germany Less << |
NCT01819389 | Leukemia, Myeloid, Chronic, BC... More >>R-ABL Positive Less << | Phase 3 | Completed | - | Mexico ... More >> Servicio de Hematologia, Hospital Universitario "José E. Gonzalez" Monterrey, Nuevo Leon, Mexico, 64460 Less << |
NCT01702064 | Chronic Phase Chronic Myeloid ... More >>Leukemia Less << | Phase 1 | Active, not recruiting | March 2019 | United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less << |
NCT01456676 | Philadelphia Chromosome Positi... More >>ve Chronic Myelogenous Leukemia Less << | Phase 1 | Completed | - | Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Marseille, France, 13273 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Roma, RM, Italy, 00161 Spain Novartis Investigative Site Pamplona, Navarra, Spain, 31008 Novartis Investigative Site Madrid, Spain, 28006 Less << |
NCT01089595 | GIST Metastat... More >>ic Disease Less << | Phase 2 | Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << | - | United States, Missouri ... More >> Siteman Cancer Center, Washington University School of Mediciine St Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less << |
NCT01528085 | Philadelphia Chromsome Positiv... More >>e Acute Lymphoblastic Leukemia Less << | PHASE2 | COMPLETED | 2020-03-10 | Centre Hospitalier du Pays d'A... More >>ix, Aix-en-Provence cedex 1, 13616, France|CHU d'Amiens - H?pital Sud, AMIENS Cedex 1, 80054, France|Chu Angers, ANGERS Cedex 09, 49933, France|Centre Hospitalier Victor Dupouy, Argenteuil Cedex, 95107, France|Centre Hospitalier de la C?te Basque, Bayonne, 64100, France|CHU de Besan?on - H?pital Jean Minjoz, BESAN?ON Cedex, 25030, France|CHU de Brest - H?pital Morvan, BREST Cedex, 29609, France|"CHU Cote de nacre ", Caen, 14000, France|CHU Estaing, Clermont Ferrand, 63003, France|AP-HP - H?pital Henri Mondor, Creteil, 94010, France|CHRU de Dijon, DIJON Cedex, 21079, France|CHU de Grenoble, Grenoble cedex 9, 38043, France|CH de Versailles - H?pital André Mignot, LE CHESNAY Cedex, 78157, France|Groupe Hospitalier de l'Institut Catholique de Lille, h?pital Saint-Vincent, Lille Cedex, 59020, France|CHRU de Lille, LILLE Cedex, 59037, France|C H U de Limoges - H?pital Dupuytren, LIMOGES Cedex, 87042, France|Institut Paoli-Calmettes, Marseille cedex 9, 13273, France|CH de Meaux, MEAUX Cedex, 77104, France|H?pital Saint-Eloi, MONTPELLIER Cedex 5, 34295, France|CH de Mulhouse - H?pital Emile Muller, MULHOUSE Cedex, 68070, France|CHU H?tel Dieu, Nantes, Nantes, 44000, France|CHU de Nice - H?pital l'Archet 1, Nice, 06200, France|CHR d'Orléans - H?pital La Source, ORLEANS Cedex, 45032, France|AP-HP - H?pital Saint Louis, PARIS Cedex 10, 75010, France|AP-HP - H?pital SAINT-ANTOINE, PARIS cedex 12, 75571, France|AP-HP - H?pital Necker, PARIS Cedex 15, 75743, France|CH de Perpignan - H?pital Saint-Jean, PERPIGNAN cedex 09, 66046, France|CHU de Bordeaux - H?pital Haut-Lévêque, PESSAC Cedex, 33604, France|Centre Hospitalier Lyon Sud, Pierre-Bénite Cedex, 69495, France|CHU de Poitiers - H?pital La Milétrie, POITIERS Cedex, 86021, France|CH de la Région d'Annecy, Pringy Cedex, 74374, France|CHU de Reims - H?pital Robert Debré, REIMS Cedex, 51092, France|CHU de Rennes, H?pital Pontchaillou, RENNES Cedex 9, 35033, France|Centre Henri Becquerel, Rouen, Rouen Cedex 1, 76038, France|CHU de La Réunion - H?pital Félix Guyon, SAINT DENIS Cedex, 97405, France|CHRU de Strasbourg - H?pital Hautepierre, STRASBOURG Cedex, 67098, France|HIA Sainte Anne, TOULON Cedex 9, 83041, France|"Institut Universitaire du Cancer (CHU de Toulouse - H?pital Purpan)", Toulouse, 31100, France|CHRU de Tours - H?pital Bretonneau, TOURS Cedex 9, 37044, France|Centre Hospitalier de Valenciennes, VALENCIENNES Cedex, 59322, France|CHU de Nancy - H?pital Brabois, Vandoeuvre Les Nancy, 54511, France|Robert Bosch Krankenhaus, Stuttgart, Baden-Württemberg, 70376, Germany|Klinikum der Universit?t Regensburg, Regensburg, Bayern, 93042, Germany|University Hospital of Frankfurt, Medical Dept. II, Frankfurt, Hessen, 60590, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, 30625, Germany|Universit?tsklinikum Essen, Essen, NRW, 45147, Germany|Universit?tsklinik Münster, Münster, NRW, 48149, Germany|Universit?tsklinik Dresden, Dresden, Sachsen, 01307, Germany|Uniklinik Aachen, Aachen, 52074, Germany|Charité Universit?tsmedizin Berlin, Berlin, 13353, Germany|University Hospital Düsseldorf, Düsseldorf, 40225, Germany|Universit?tsklinikum G?ttingen, G?ttingen, 37075, Germany|Asklepios Klinik St. Georg, Hamburg, 20099, Germany|Universit?tsklinikum Schleswig-Holstein Campus Kiel, Kiel, 24116, Germany|Universit?t Leipzig, José-Carreras-Haus, Leipzig, 04103, Germany|Universit?tskliniken Mainz, Mainz, 55101, Germany|Klinikum Mannheim, Mannheim, 68167, Germany|Universit?tsklinikum Gro?hadern, München, 81377, Germany|Klinikum Nürnberg Nord, Nürnberg, 90419, Germany|Klinikum Oldenburg, Oldenburg, 26133, Germany|Universit?t Rostock, Rostock, 18055, Germany|Medizinische Universit?tsklinik Ulm, Ulm, 89070, Germany|Universit?t Würzburg, Würzburg, 97080, Germany|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario Germans Trias i Pujol (ICO - Badalona), Barcelona, 08916, Spain|Hospital Universitario 12 de Octubre (Madrid), Madrid, 28041, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, 37007, Spain|Hospital Universitario Virgen del Rocío (Sevilla), Sevilla, 41013, Spain|Hospital Universitario y Politécnico La Fe (Valencia), Valencia, 46026, Spain Less << |
NCT01270893 | Gastrointestinal Cancer | PHASE2 | WITHDRAWN | - | - |
NCT00788775 | Mucosal Lentiginous Melanoma|A... More >>cral Melanoma|Melanoma Less << | PHASE2 | COMPLETED | 2025-03-14 | The Angeles Clinic and Researc... More >>h Institute, Santa Monica, California, 90404, United States|University of Colorado, Aurora, Colorado, 80045, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States Less << |
NCT02253277 | Chronic Myeloid Leukemia | Phase 1 Phase 2 | Completed | - | Germany ... More >> Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mannheim, Germany, 68169 Less << |
NCT01207492 | Pigmented Villonodular Synovit... More >>is Diffuse-type Giant Cell Tumor Tenosynovial Giant Cell Tumor Less << | Phase 2 | Active, not recruiting | December 2018 | United States, California ... More >> Sarcoma Oncology Center Santa Monica, California, United States, 90403 Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT01089595 | - | Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << | - | - | |
NCT01207492 | - | Active, not recruiting | - | - | |
NCT01222143 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Terminated | - | Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
NCT01784068 | Chronic Myelogenous Leukemia | Phase 2 | Recruiting | February 28, 2025 | - |
NCT02108951 | Philidelphia Positive Chronic ... More >>Myeloid Leukaemia Less << | PHASE3 | TERMINATED | 2016-08-10 | Novartis Investigative Site, C... More >>anberra, Australian Capital Territory, 2605, Australia|Novartis Investigative Site, Kingswood, New South Wales, 2747, Australia|Novartis Investigative Site, Kogarah, New South Wales, 2217, Australia|Novartis Investigative Site, Liverpool, New South Wales, 2170, Australia|Novartis Investigative Site, St. Leonards, New South Wales, 2065, Australia|Novartis Investigative Site, Douglas, Queensland, 4810, Australia|Novartis Investigative Site, Nambour, Queensland, 4560, Australia|Novartis Investigative Site, South Brisbane, Queensland, 4101, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Fitzroy, Victoria, 3065, Australia|Novartis Investigative Site, Geelong, Victoria, 3220, Australia|Novartis Investigative Site, Melbourne, Victoria, 3000, Australia|Novartis Investigative Site, Murdoch, Western Australia, 6150, Australia|Novartis Investigative Site, Nedlands, Western Australia, 6009, Australia Less << |
NCT02108951 | Philidelphia Positive Chronic ... More >>Myeloid Leukaemia Less << | PHASE3 | TERMINATED | 2016-08-10 | Novartis Investigative Site, C... More >>anberra, Australian Capital Territory, 2605, Australia|Novartis Investigative Site, Kingswood, New South Wales, 2747, Australia|Novartis Investigative Site, Kogarah, New South Wales, 2217, Australia|Novartis Investigative Site, Liverpool, New South Wales, 2170, Australia|Novartis Investigative Site, St. Leonards, New South Wales, 2065, Australia|Novartis Investigative Site, Douglas, Queensland, 4810, Australia|Novartis Investigative Site, Nambour, Queensland, 4560, Australia|Novartis Investigative Site, South Brisbane, Queensland, 4101, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Fitzroy, Victoria, 3065, Australia|Novartis Investigative Site, Geelong, Victoria, 3220, Australia|Novartis Investigative Site, Melbourne, Victoria, 3000, Australia|Novartis Investigative Site, Murdoch, Western Australia, 6150, Australia|Novartis Investigative Site, Nedlands, Western Australia, 6009, Australia Less << |
NCT01743989 | Philadelphia Chromosome Positi... More >>ve (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Less << | PHASE3 | COMPLETED | 2020-07-08 | Novartis Investigative Site, L... More >>inz, Oberoesterreich, A 4020, Austria|Novartis Investigative Site, Graz, 8036, Austria|Novartis Investigative Site, Linz, 4010, Austria|Novartis Investigative Site, Linz, A-4010, Austria|Novartis Investigative Site, Rankweil, A-6830, Austria|Novartis Investigative Site, Salzburg, 5020, Austria|Novartis Investigative Site, Bruxelles, 1070, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Pleven, 5800, Bulgaria|Novartis Investigative Site, Plovdiv, 4002, Bulgaria|Novartis Investigative Site, Sofia, 1431, Bulgaria|Novartis Investigative Site, Sofia, 1756, Bulgaria|Novartis Investigative Site, Varna, 9000, Bulgaria|Novartis Investigative Site, Brno Bohunice, Czech Republic, 625 00, Czechia|Novartis Investigative Site, Hradec Kralove, CZE, 500 05, Czechia|Novartis Investigative Site, Holstebro, DK-7500, Denmark|Novartis Investigative Site, Roskilde, 4000, Denmark|Novartis Investigative Site, HUS Helsinki, FIN-00029, Finland|Novartis Investigative Site, Bayonne, Bayonne Cedex, 64109, France|Novartis Investigative Site, Le Mans, Cedex 09, 72037, France|Novartis Investigative Site, Paris Cedex 10, Cedex 10, 75475, France|Novartis Investigative Site, Caen, Cedex, 14033, France|Novartis Investigative Site, Angers Cedex 1, 49033, France|Novartis Investigative Site, Bordeaux Cedex, 33000, France|Novartis Investigative Site, Bordeaux, 33076, France|Novartis Investigative Site, Chalon sur Sa?ne, 71321, France|Novartis Investigative Site, Chambéry cedex, 73011, France|Novartis Investigative Site, Clermont Ferrand cedex 1, 63003, France|Novartis Investigative Site, Corbeil Essonnes, 91100, France|Novartis Investigative Site, Dunkerque, 59240, France|Novartis Investigative Site, Grenoble, 38043, France|Novartis Investigative Site, La Roche sur Yon cedex 9, 85925, France|Novartis Investigative Site, Lille cedex, 59020, France|Novartis Investigative Site, Lille, 59037, France|Novartis Investigative Site, Lyon Cedex, 69373, France|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Metz, 57000, France|Novartis Investigative Site, Metz, 57085, France|Novartis Investigative Site, Mulhouse cedex, 68070, France|Novartis Investigative Site, Nice Cedex, 06202, France|Novartis Investigative Site, Paris, 75012, France|Novartis Investigative Site, Perpignan, 66046, France|Novartis Investigative Site, Pontoise, F-95300, France|Novartis Investigative Site, Rouen Cedex 1, 76038, France|Novartis Investigative Site, Saint Priest en Jarez, 42271, France|Novartis Investigative Site, Toulouse, 31059, France|Novartis Investigative Site, Mannheim, Baden-Wuerttemberg, 68305, Germany|Novartis Investigative Site, Augsburg, 86150, Germany|Novartis Investigative Site, Bayreuth, 95445, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Braunschweig, 38114, Germany|Novartis Investigative Site, Bremen, 28177, Germany|Novartis Investigative Site, Chemnitz, 09113, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Eisenach, 99817, Germany|Novartis Investigative Site, Frankfurt, 60596, Germany|Novartis Investigative Site, Georgsmarienhuette, 49124, Germany|Novartis Investigative Site, Halle, 06110, Germany|Novartis Investigative Site, Hamm, 59063, Germany|Novartis Investigative Site, Kiel, 24105, Germany|Novartis Investigative Site, Koeln, 50671, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Lütten-Klein, 18107, Germany|Novartis Investigative Site, Magdeburg, 39104, Germany|Novartis Investigative Site, Marburg, 35039, Germany|Novartis Investigative Site, Muenchen, 81241, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, Nuernberg, 90449, Germany|Novartis Investigative Site, Offenburg, 77654, Germany|Novartis Investigative Site, Potsdam, 14467, Germany|Novartis Investigative Site, Rostock, 18057, Germany|Novartis Investigative Site, Rostock, 18059, Germany|Novartis Investigative Site, Schorndorf, 73614, Germany|Novartis Investigative Site, Schw?bisch-Hall, 74523, Germany|Novartis Investigative Site, Stuttgart, 70174, Germany|Novartis Investigative Site, Velbert, 42551, Germany|Novartis Investigative Site, Westerstede, 26655, Germany|Novartis Investigative Site, Wiesbaden, 65191, Germany|Novartis Investigative Site, Wuerzburg, 97080, Germany|Novartis Investigative Site, Athens, GR, 115 27, Greece|Novartis Investigative Site, Thessaloniki, GR, 570 10, Greece|Novartis Investigative Site, Athens, 106 76, Greece|Novartis Investigative Site, Athens, 115 27, Greece|Novartis Investigative Site, Patras, 265 00, Greece|Novartis Investigative Site, Budapest, 1097, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Szeged, H 6725, Hungary|Novartis Investigative Site, Alessandria, AL, 15100, Italy|Novartis Investigative Site, Ancona, AN, 60126, Italy|Novartis Investigative Site, Avellino, AV, 83100, Italy|Novartis Investigative Site, Bari, BA, 70124, Italy|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Brescia, BS, 25123, Italy|Novartis Investigative Site, Cagliari, CA, 09126, Italy|Novartis Investigative Site, Cremona, CR, 26100, Italy|Novartis Investigative Site, Catania, CT, 95100, Italy|Novartis Investigative Site, Cona, FE, 44100, Italy|Novartis Investigative Site, San Giovanni Rotondo, FG, 71013, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Roma, Lazio, 00168, Italy|Novartis Investigative Site, Lecce, LE, 73100, Italy|Novartis Investigative Site, Livorno, LI, 57124, Italy|Novartis Investigative Site, Messina, ME, 98125, Italy|Novartis Investigative Site, Milano, MI, 20122, Italy|Novartis Investigative Site, Milano, MI, 20132, Italy|Novartis Investigative Site, Milano, MI, 20162, Italy|Novartis Investigative Site, Modena, MO, 41124, Italy|Novartis Investigative Site, Palermo, PA, 90127, Italy|Novartis Investigative Site, Palermo, PA, 90146, Italy|Novartis Investigative Site, Padova, PD, 35128, Italy|Novartis Investigative Site, Pescara, PE, 65124, Italy|Novartis Investigative Site, Pisa, PI, 56126, Italy|Novartis Investigative Site, Parma, PR, 43100, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Potenza, PZ, 85100, Italy|Novartis Investigative Site, Reggio Calabria, RC, 89124, Italy|Novartis Investigative Site, Reggio Emilia, RE, 42123, Italy|Novartis Investigative Site, Roma, RM, 00133, Italy|Novartis Investigative Site, Roma, RM, 00144, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Pagani, SA, 84016, Italy|Novartis Investigative Site, Siena, SI, 53100, Italy|Novartis Investigative Site, Taranto, TA, 74100, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Torino, TO, 10126, Italy|Novartis Investigative Site, Treviso, TV, 31100, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Mirano, VE, 30035, Italy|Novartis Investigative Site, Venezia, VE, 30174, Italy|Novartis Investigative Site, Vicenza, VI, 36100, Italy|Novartis Investigative Site, Verona, VR, 37126, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Novara, 28100, Italy|Novartis Investigative Site, Perugia, 06129, Italy|Novartis Investigative Site, Bergen, NO-5021, Norway|Novartis Investigative Site, Oslo, NO-0310, Norway|Novartis Investigative Site, Chorzow, 41-500, Poland|Novartis Investigative Site, Gdansk, 80 952, Poland|Novartis Investigative Site, Katowice, 40-027, Poland|Novartis Investigative Site, Krakow, 30-510, Poland|Novartis Investigative Site, Olsztyn, 10 561, Poland|Novartis Investigative Site, Opole, 45-372, Poland|Novartis Investigative Site, Torun, 87 100, Poland|Novartis Investigative Site, Warszawa, 02 106, Poland|Novartis Investigative Site, Warszawa, 02 776, Poland|Novartis Investigative Site, Lisboa, 1099 023, Portugal|Novartis Investigative Site, Lisboa, 1749-035, Portugal|Novartis Investigative Site, Porto, 4099-001, Portugal|Novartis Investigative Site, Porto, 4200 319, Portugal|Novartis Investigative Site, Porto, 4200-072, Portugal|Novartis Investigative Site, Bucharest, District 2, 022328, Romania|Novartis Investigative Site, Bucharest, 030 171, Romania|Novartis Investigative Site, Bucharest, 500098, Romania|Novartis Investigative Site, Cluj-Napoca, 400124, Romania|Novartis Investigative Site, Iasi, 700483, Romania|Novartis Investigative Site, Sibiu, 550245, Romania|Novartis Investigative Site, Timisoara, 300 079, Romania|Novartis Investigative Site, Belgrade, 11000, Serbia|Novartis Investigative Site, Belgrade, 11070, Serbia|Novartis Investigative Site, Nis, 18000, Serbia|Novartis Investigative Site, Novi Sad, Serbia|Novartis Investigative Site, Bratislava, 85107, Slovakia|Novartis Investigative Site, Martin, 03601, Slovakia|Novartis Investigative Site, Ljubljana, 1000, Slovenia|Novartis Investigative Site, Granada, Andalucia, 18014, Spain|Novartis Investigative Site, Jaen, Andalucia, 23007, Spain|Novartis Investigative Site, Malaga, Andalucia, 29010, Spain|Novartis Investigative Site, Sevilla, Andalucia, 41009, Spain|Novartis Investigative Site, Sevilla, Andalucia, 41013, Spain|Novartis Investigative Site, Sabadell, Barcelona, 08208, Spain|Novartis Investigative Site, León, Castilla Y Leon, 24071, Spain|Novartis Investigative Site, Salamanca, Castilla Y Leon, 37007, Spain|Novartis Investigative Site, Valladolid, Castilla Y Leon, 47011, Spain|Novartis Investigative Site, Badalona, Catalunya, 08916, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Girona, Catalunya, 17007, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, 08907, Spain|Novartis Investigative Site, Tarragona, Catalunya, 43005, Spain|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03010, Spain|Novartis Investigative Site, Alzira, Comunidad Valenciana, 46600, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46026, Spain|Novartis Investigative Site, Caceres, Extremadura, 10003, Spain|Novartis Investigative Site, La Coruna, Galicia, 15006, Spain|Novartis Investigative Site, Pontevedra, Galicia, 36071, Spain|Novartis Investigative Site, Santiago de Compostela, Galicia, 15706, Spain|Novartis Investigative Site, Palma De Mallorca, Islas Baleares, 07120, Spain|Novartis Investigative Site, Pamplona, Navarra, 31008, Spain|Novartis Investigative Site, San Sebastian, Pais Vasco, 20080, Spain|Novartis Investigative Site, Granollers, 08402, Spain|Novartis Investigative Site, Madrid, 28006, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Madrid, 28031, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Madrid, 28222, Spain|Novartis Investigative Site, Murcia, 30008, Spain|Novartis Investigative Site, Santa Cruz de Tenerife, 38009, Spain|Novartis Investigative Site, Zaragoza, 50009, Spain|Novartis Investigative Site, Stockholm, SE-171 76, Sweden|Novartis Investigative Site, East Yorkshire, HU16 5JQ, United Kingdom|Novartis Investigative Site, Edinburgh, EH4 2XU, United Kingdom|Novartis Investigative Site, London, EC1A 7BE, United Kingdom|Novartis Investigative Site, London, W12 0HS, United Kingdom Less << |
NCT01395121 | Mucosal Lentiginous Melanoma ... More >> Acral Lentiginous Malignant Melanoma Less << | Phase 2 | Completed | - | United Kingdom ... More >> Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Less << |
NCT00976612 | Gastrointestinal Stromal Tumor... More >>s Less << | COMPLETED | 2025-12-11 | Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less << | |
NCT02917720 | Chronic Myeloid Leukemia | Phase 2 | Recruiting | May 2023 | Germany ... More >> Universitätsklinikum der RWTH Recruiting Aachen, Germany, 52074 Contact: Tim H. Brümmendorf, Dr. med. Klinikum Bayreuth Recruiting Bayreuth, Germany, 95445 Contact: Alexander Kiani, Dr. med. Vivantes Klinikum Neukölln Not yet recruiting Berlin, Germany, 12351 Contact: Maike de Wit, Dr. med. Klinikum Chemnitz Recruiting Chemnitz, Germany, 09113 Contact: Mathias Hänel, Dr. med. Onkologische Schwerpunktpraxis Not yet recruiting Esslingen, Germany, 73728 Contact: Robert Eckert, Dr. med. Centrum für Hämatologie und Onkologie Bethanien Recruiting Frankfurt, Germany, 60389 Contact: Hans Tesch, Dr. med. Schwerpunktpraxis Onkologie Recruiting Heilbronn, Germany, 74072 Contact: Jolanta Dengler, Dr. med. Universitätsklinikum Jena Recruiting Jena, Germany, 07740 Contact: Andreas Hochhaus Less << |
NCT01863745 | Gastrointestinal Stromal Tumor... More >>s Less << | Phase 2 | Active, not recruiting | October 4, 2023 | Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Gifu-city, Gifu, Japan, 501-1194 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 241-8515 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-8556 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Kurashiki, Okayama, Japan, 701-0192 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less << |
NCT02973711 | Leukemia, Chronic Myeloid | Phase 1 Phase 2 | Recruiting | April 2021 | United States, Michigan ... More >> The University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Patrick Burke, M.D. 734-647-8921 pwburke@umich.edu Principal Investigator: Patrick Burke, M.D. United States, North Carolina Wake Forest University Health Sciences Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Rupali Bhave, M.D. 336-713-0864 rbhave@wakehealth.edu Contact: Megan Brown-Farmer 336-713-6913 mebrown@wakehealth.edu Less << |
NCT01131325 | CML Philadelp... More >>hia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels Less << | Phase 4 | Terminated | - | United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada CCC of Nevada (1) Las Vegas, Nevada, United States, 89109 United States, Texas Cancer Center of the High Plains Amarillo, Texas, United States, 79106 Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) Dallas, Texas, United States, 75246 Less << |
NCT01914484 | Chronic Phase Chronic Myeloid ... More >>Leukemia Accelerated Phase Chronic Myeloid Leukemia Blastic Phase Chronic Myeloid Leukemia Philadelphia Positive Acute Lymphoblastic Leukemia Resistant to Tyrosine Kinase Inhibitor Therapy Less << | Phase 1 Phase 2 | Unknown | July 2016 | Canada, Ontario ... More >> Princess Margaret Hospital / University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Sima Bogomilsky, RN BScN CON(C) 416-946-4646 sima.bogomilsky@uhn.on.ca Contact: Sonal Malhotra, M.Sc., Ph.D,CCRP 416-946-4501 ext 3449 sonal.malhotra@uhn.ca Principal Investigator: Dennis Kim, MD/PhD Sub-Investigator: Jeffrey H Lipton, MD/PhD Less << |
NCT01810718 | Chronic Graft Versus Host Dise... More >>ase Less << | Phase 1 | Completed | - | Israel ... More >> Chaim Sheba Medical Center Tel Hashomer, Israel Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Trapianti Midollo Osseo - Div. di Ematologia 2 - Ospedale S. Martino Genova, Italy Ospedale Panico Lecce, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy Ospedale Niguarda Ca' Grande Milano, Italy U.O. Ematologia I - Centro Trapianti di Midollo - Ospedale Maggiore - Policlinico Mangiagalli e Regina Elena Milano, Italy Ospedale San Carlo Potenza, Italy Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli Reggio Calabria, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Clinica Ematologica - AOU Santa Maria Della Misericordia Udine, Italy Less << |
NCT00980018 | Chronic Myelogenous Leukemia | PHASE4 | COMPLETED | 2025-12-12 | Highlands Oncology Group, Faye... More >>tteville, Arkansas, 72703, United States|Hematology Oncology Services of Arkansas SC, Little Rock, Arkansas, 72205, United States|USC Norris Cancer Center LAC & USC Medical Center, Los Angeles, California, 90033, United States|Southwest Cancer Care Murrieta, Poway, California, 92064, United States|Rocky Mountain Cancer Centers RMCC - Aurora, Greenwood Village, Colorado, United States|Florida Cancer Institute, New Port Richey, Florida, 34655, United States|Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4, Ocoee, Florida, *see dep*, United States|Stroger Cook County Hospital John H. Stroger Hospital, Chicago, Illinois, 60612, United States|St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn, Beech Grove, Indiana, 46107, United States|St. Agnes Hospital, Baltimore, Maryland, 21229, United States|St. Louis University Cancer Center, Saint Louis, Missouri, 63110, United States|Northwest Cancer Specialists Salmon Creek Office, Portland, Oregon, 97210, United States|Oregon Health Sciences University, Portland, Oregon, 97239, United States|The Jones Clinic, Germantown, Tennessee, 38138, United States|Texas Oncology, P.A., Bedford, Texas, 76022, United States|Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp, Dallas, Texas, 75231, United States|Texas Oncology Texas Oncology - Sugar Land, Dallas, Texas, 75246, United States|MD Anderson Cancer Center/University of Texas, Houston, Texas, 77031, United States|Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2), San Antonio, Texas, 78229, United States|Novartis Investigative Site, Brampton, Ontario, L6R 3J7, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Montreal, Quebec, H3A 1A1, Canada Less << |
NCT01316250 | Chronic Myelogenous Leukemia | RECRUITING | 2025-07-25 | American University of Beirut ... More >>Medical Center, Beirut, Lebanon Less << | |
NCT02891395 | Graft Versus Host Disease | Phase 2 | Active, not recruiting | December 2018 | Belgium ... More >> CHU Sart Tilman Liège, Belgium France CHU d'Amiens Amiens, France CHU d'Angers Angers, France CHU Besançon Besancon, France CHU Bordeaux Bordeaux, France Hopital Morvan Brest, France CHU Clémenceau Caen, France HIA de Percy Clamart, France CHU de Clermont Ferrand Clermont Ferrand, France CHU Grenoble Grenoble, France Diseases of Blood Service HURIEZ hospital CHRU de LILLE LIlle, France, 59037 Centre hospitalier et régional de Lille Lille, France CHU de Lyon Lyon, France Institut Paoli Calmettes Marseille, France Hôpital Saint Eloi Montpellier, France CHU Hotel Dieu Nantes, France CHU de Nice Nice, France Hopital NECKER Paris, France Hôpital pitié Salpetrière Paris, France Centre Henri Becquerel Rouen, France CHU de STRASBOURG Strasbourg, France CHU Purpan Toulouse, France Less << |
NCT01698905 | Chronic Myeloid Leukemia | Phase 2 | Active, not recruiting | February 6, 2025 | - |
NCT02379416 | Solid Tumors | Phase 1 | Recruiting | November 19, 2020 | United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
NCT03332511 | Chronic Myeloid Leukemia, Chro... More >>nic Phase Less << | PHASE4 | COMPLETED | 2016-10-24 | - |
NCT01856283 | Leukemia, Myeloid, Chronic-Pha... More >>se Less << | Phase 2 | Active, not recruiting | June 2019 | Italy ... More >> A.O. Ospedale S. Antonio Gallarate, Milano, Italy Ospedale Desio- "Ospedale Civile" di Vimercate, Desio, Carate Brianza, Giussano, Seregno. Vimercate, Milano, Italy A.O di Circolo di Busto Arsizio Busto Arsizio, Varese, Italy Ospedali Riuniti Bergamo Bergamo, Italy Spedali Civili Brescia Brescia, Italy Ospedale Valduce Como, Italy Istituti Ospitalieri di Cremona Cremona, Italy A.O Ospedale Lecco Lecco, Italy Ospedale San Raffaele Milano, Italy, Italy A.O Sacco Milano, Italy Istituto dei Tumori Milano, Italy Istituto Europeo Oncologia Milano, Italy Ospedale Maggiore Policlinico Milano, Italy Ospedale S. Paolo Milano, Italy S. Gerardo di Monza Monza, Italy Policlinico S.Matteo Pavia Pavia, Italy A.O. Universitaria Fondazione Macchi Varese, Italy Less << |
NCT01562847 | Chronic Myeloid Leukemia | UNKNOWN | 2025-06-15 | Seoul St. Mary's Hospital, Seo... More >>ul, 137-701, Korea, Republic of Less << | |
NCT02281474 | Parkinson's Disease|Parkinson'... More >>s Disease Dementia|Diffuse Lewy Body Disease Less << | PHASE1 | COMPLETED | - | MedStar Georgetown University ... More >>Hospital, Washington, District of Columbia, 20007, United States Less << |
NCT02201459 | Chronic Myeloid Leukemia | Phase 3 | Recruiting | August 2019 | France ... More >> Franck NICOLINI Recruiting Lyon, France, 04 78 86 22 50 Contact: Franck Nicolini, MD 4 78 86 22 50 ext 33 franck-emmanuel.nicolini@chu-lyon.fr Less << |
NCT03764215 | Huntington Disease | Phase 1 | Recruiting | May 31, 2020 | United States, District of Col... More >>umbia Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Hope Heller 202-687-1366 hope.heller@gunet.georgetown.edu Contact: Robin Kuprewicz, MA rk1028@georgetown.edu Less << |
NCT02086487 | Myeloid Leukemia, Chronic | Phase 4 | Terminated(Because of many uns... More >>een obstacles resulted in poor accrual, study is terminated.) Less << | - | Saudi Arabia ... More >> National Guard Hospital Riyadh, Central, Saudi Arabia, 11426 King Fahad specialist Hospital Dammam, Eastern, Saudi Arabia Less << |
NCT02587169 | Retroperitoneal Liposarcoma ... More >> Retroperitoneal Leiomyosarcoma Chondrosarcoma Less << | Phase 1 Phase 2 | Unknown | December 2015 | Spain ... More >> Hospital Universitari Son Espases Recruiting Palma de Mallorca, Balearic Islands, Spain Contact: Javier Martín, MD, PhD +34 871205705 javier.martin@ssib.es Principal Investigator: Javier Martín, MD, PhD Hospital Infanta Cristina Recruiting Badajoz, Spain Contact: Ignacio Delgado, MD ignadelgado@hotmail.com Principal Investigator: Ignacio Delgado, MD Hospital Universitari Germans Trials i Pujol Recruiting Badalona, Spain Contact: Olatz Etxaniz, MD oetxaniz@iconcologia.net Principal Investigator: Olatz Etxaniz, MD Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain Contact: Antonio López-Pousa, MD alopezp@santpau.cat Principal Investigator: Antonio López-Pousa, MD Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain Contact: Claudia Valverde, MD cmvalver@vhebron.net Principal Investigator: Claudia Valverde, MD Hospital Provincial de Castellón Recruiting Castellón, Spain Contact: Ramón de las Peñas, MD ramon.delaspenas@hospital2000.net Principal Investigator: Ramón de las Peñas, MD Hospital Universitario de Canarias Recruiting La Laguna, Spain Contact: Josefina Cruz, MD jcruzjurado@gmail.com Principal Investigator: Josefina Cruz, MD Complejo Asistencial Universitario de León Recruiting León, Spain Contact: Luis Miguel de Sande, MD lmgdesande@hotmail.com Principal Investigator: Luis Miguel de Sande, MD Hospital Puerta de Hierro Recruiting Madrid, Spain Contact: Ricardo Cubedo, MD rcubedo@gmail.com Principal Investigator: Ricardo Cubedo, MD Hospital Universitario La Paz Recruiting Madrid, Spain Contact: Andrés Redondo, MD aredondo12@gmail.com Principal Investigator: Andrés Redondo, MD Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain Contact: Mª Ángeles Vaz, MD mavaz3@yahoo.es Principal Investigator: Mª Ángeles Vaz, MD Hospital Universitario Virgen de la Arrixaca Recruiting Murcia, Spain Contact: Jerónimo Martínez, MD jeronimo@seom.org Principal Investigator: Jerónimo Martínez, MD Complejo Hospitalario de Navarra Recruiting Pamplona, Spain Contact: Nuria Láinez, MD nuria.lainez.milagro@cfnavarra.es Principal Investigator: Nuria Láinez, MD Hospital Marqués de Valdecilla Recruiting Santander, Spain Contact: Ana de Juan, MD ajuan@humv.es Principal Investigator: Ana de Juan, MD Hospital Clínico Universitario de Santiago Recruiting Santiago de Compostela, Spain Contact: Yolanda Vidal, MD yvidalinsua@yahoo.es Principal Investigator: Yolanda Vidal, MD Hospital Virgen del Rocío Recruiting Sevilla, Spain Contact: Pilar Sancho, MD sanchomarquez@gmail.com Principal Investigator: Pilar Sancho, MD Hospital Virgen de la Salud Recruiting Toledo, Spain Contact: Javier Medina, MD boladiez39@yahoo.es Principal Investigator: Javier Medina, MD Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: Javier Lavernia, MD javilavernia@hotmail.com Principal Investigator: Javier Lavernia, MD Hospital Xeral Cies Recruiting Vigo, Spain Contact: Juan Antonio Carrasco, MD juan.antonio.carrasco.alvarez@sergas.es Principal Investigator: Juan Antonio Carrasco, MD Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain Contact: Javier Martínez-Trufero, MD jmtrufero@seom.org Principal Investigator: Javier Martínez-Trufero, MD Less << |
NCT01690065 | Chronic Myeloid Leukemia in My... More >>eloid Blast Crisis Untreated Adult Acute Myeloid Leukemia Less << | Phase 2 | Recruiting | December 2019 | Korea, Republic of ... More >> Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Wook Kim, M.D., Ph.D. dwkim@catholic.ac.kr Principal Investigator: Dong-Wook Kim, M.D., Ph.D. Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 682714 Principal Investigator: Hawk Kim, M.D., Ph.D. Sub-Investigator: Jae-Hoo Park, M.D., Ph.D. Sub-Investigator: Jae-Cheol Jo, M.D., Ph.D. Less << |
NCT02954978 | Parkinson Disease ... More >> Parkinsons Disease With Dementia Less << | Phase 2 | Active, not recruiting | July 2020 | United States, District of Col... More >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 Less << |
NCT02947893 | Alzheimer's Disease | Phase 2 | Recruiting | December 2019 | United States, District of Col... More >>umbia Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Ashot R Shekoyan, MD, PhD 202-687-7591 ars232@georgetown.edu Contact: Charbel E Moussa, MD, PhD 202-687-7328 cem46@georgetown.edu Principal Investigator: Scott R. Turner, MD, PhD Less << |
NCT00302016 | Chronic Myeloid Leukemia | NO_LONGER_AVAILABLE | - | University of South Alabama Ca... More >>ncer Research Institute, Mobile, Alabama, 36693, United States|Arizona Cancer Center, Tucson, Arizona, 85724, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|Antelope Valley Cancer Center, Lancaster, California, 93534, United States|Stanford University, Palo Alto, California, 94304, United States|University of Colorado, Aurora, Colorado, 80010, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|Georgetown University Medical Center-Lombardi Cancer Center, Washington, District of Columbia, 20007-2113, United States|Washington Cancer Institute, Washington, District of Columbia, 20010, United States|Osler Medical Inc./Osler Clinical Research, Melbourne, Florida, 32901, United States|Advanced Medical Specialties, Miami, Florida, 33176, United States|Integrated Community, Orange Park, Florida, 32073, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|MD Anderson Cancer Center, Orlando, Florida, 32806, United States|Hematology Oncology Assoc., Pensacola, Florida, 32501, United States|Emory University Cancer Institute, Atlanta, Georgia, 30322, United States|Medical College of Georgia, Augusta, Georgia, 30912, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Stroger Cook County Hospital, Chicago, Illinois, 60612, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States|University of Chicago Hospital, Chicago, Illinois, 60637, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|St. Francis Hospital & Health Centers, Beech Grove, Indiana, 46107, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, 52242, United States|Cancer Center of Kansas, Wichita, Kansas, 67214, United States|Louisville Oncology Research, Louisville, Kentucky, 40202, United States|LSU Health Sciences Center, Shreveport, Louisiana, 71103, United States|St. Agnes Hospital, Baltimore, Maryland, 21229, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Wayne State University, Detroit, Michigan, 48201, United States|St. John Hospital and Medical Center, Grosse Pointe, Michigan, 48236, United States|Mayo Clinic Hospital, Rochester, Minnesota, 55905, United States|Southeast Nebraska Cancer Center, Lincoln, Nebraska, 68516, United States|Nebraska Methodist Cancer Center, Omaha, Nebraska, 68114, United States|Nevada Cancer Institute, Las Vegas, Nevada, 89135, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87131, United States|Cancer Institute of New Mexico, Santa Fe, New Mexico, 87505, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Winthrop Hematology/Oncology, Mineola, New York, 11501, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10017, United States|Weill Cornell Medical Center, New York, New York, 10021, United States|Mount Sinai Medical Center, New York, New York, 10029, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Duke University, Durham, North Carolina, 27710, United States|Wake Forest University, Winston Salem, North Carolina, 27157, United States|Cancer Care Associates, Oklahoma City, Oklahoma, 734112, United States|Cancer Care Associates, Tulsa, Oklahoma, 74136, United States|Oregon Health Sciences University, Portland, Oregon, 97239, United States|Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, 15224, United States|Charleston Hematology Oncology, Charleston, South Carolina, 29403, United States|MUSC Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Three Medical Park, Columbia, South Carolina, 29203, United States|Cancer Center of the Carolinas, Greenville, South Carolina, 29615, United States|The Jones Clinic, Germantown, Tennessee, 38138, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Novartis Investigative Site, Saint Leonards, Australia|Novartis Investigative Site, Graz, Austria|Novartis Investigative Site, Innsbruck, Austria|Novartis Investigative Site, Linz, Austria|Novartis Investigative Site, Wels, Austria|Novartis Investigative Site, Wien, Austria|Novartis Investigative Site, Aalst, Belgium|Novartis Investigative Site, Antwerpen, Belgium|Novartis Investigative Site, Arlon, Belgium|Novartis Investigative Site, Brugge, Belgium|Novartis Investigative Site, Brussels, Belgium|Novartis Investigative Site, Bruxelles, Belgium|Novartis Investigative Site, Edegem, Belgium|Novartis Investigative Site, Gent, Belgium|Novartis Investigative Site, Hasselt, Belgium|Novartis Investigative Site, La Louviere, Belgium|Novartis Investigative Site, Leuven, Belgium|Novartis Investigative Site, Liege, Belgium|Novartis Investigative Site, Roeselare, Belgium|Novartis Investigative Site, Verviers, Belgium|Novartis Investigative Site, Yvoir, Belgium|Novartis Investigative Site, Belo Horizonte, Brazil|Novartis Investigative Site, Brasilia-DF, Brazil|Novartis Investigative Site, Campinas, Brazil|Novartis Investigative Site, Curitaba, Brazil|Novartis Investigative Site, Curitiba, Brazil|Novartis Investigative Site, Porto Alegre-RS, Brazil|Novartis Investigative Site, Ribeirao Preto, Brazil|Novartis Investigative Site, Rio de Janeiro, Brazil|Novartis Investigative Site, Sao Paulo, Brazil|Novartis Investigative Site, Edmonton, Canada|Novartis Investigative Site, Halifax, Canada|Novartis Investigative Site, Hamilton, Canada|Novartis Investigative Site, Montreal, Canada|Novartis Investigative Site, Ottawa, Canada|Novartis Investigative Site, Toronto, Canada|Novartis Investigative Site, Vancouver, Canada|Novartis Investigative Site, Beijing, China|Novartis Investigative Site, Guangzhou, China|Novartis Investigative Site, Shanghai, China|Novartis Investigative Site, Tianjing, China|Novartis Investigative Site, Brno, Czech Republic|Novartis Investigative Site, Hradec Kralove, Czech Republic|Novartis Investigative Site, Olomouc, Czech Republic|Novartis Investigative Site, Plzen-Lochotin, Czech Republic|Novartis Investigative Site, Praha 2, Czech Republic|Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Vejle, Denmark|Novartis Investigative Site, Angers, France|Novartis Investigative Site, Bordeaux, France|Novartis Investigative Site, Caen, France|Novartis Investigative Site, Clermont-Ferrand, France|Novartis Investigative Site, Creteil, France|Novartis Investigative Site, Dijon, France|Novartis Investigative Site, Grenoble, France|Novartis Investigative Site, Le Chesnay, France|Novartis Investigative Site, Lille, France|Novartis Investigative Site, Limoges, France|Novartis Investigative Site, Lyon, France|Novartis Investigative Site, Marseille, France|Novartis Investigative Site, Nantes, France|Novartis Investigative Site, Nice, France|Novartis Investigative Site, Paris, France|Novartis Investigative Site, Poitiers, France|Novartis Investigative Site, Reims, France|Novartis Investigative Site, Rennes, France|Novartis Investigative Site, Rouen, France|Novartis Investigative Site, Strasbourg, France|Novartis Investigative Site, Toulouse, France|Novartis Investigative Site, Vandoeuvre les Nancy, France|Novartis Investigative Site, Vandoeuvre, France|Novartis Investigative Site, Aschaffenburg, Germany|Novartis Investigative Site, Augsburg, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Braunschweig, Germany|Novartis Investigative Site, Bremen, Germany|Novartis Investigative Site, Bremerhaven, Germany|Novartis Investigative Site, Chemnitz, Germany|Novartis Investigative Site, Dresden, Germany|Novartis Investigative Site, Essen, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Freiburg, Germany|Novartis Investigative Site, Greifswald, Germany|Novartis Investigative Site, Hamburg, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Heidelberg, Germany|Novartis Investigative Site, Kiel, Germany|Novartis Investigative Site, Koln, Germany|Novartis Investigative Site, Leipzig, Germany|Novartis Investigative Site, Mainz, Germany|Novartis Investigative Site, Mannheim, Germany|Novartis Investigative Site, Marburg, Germany|Novartis Investigative Site, Munchen, Germany|Novartis Investigative Site, Oldenburg, Germany|Novartis Investigative Site, Osnabruck, Germany|Novartis Investigative Site, Regensburg, Germany|Novartis Investigative Site, Stuttgart, Germany|Novartis Investigative Site, Tubingen, Germany|Novartis Investigative Site, Ulm, Germany|Novartis Investigative Site, Weiden, Germany|Novartis Investigative Site, Wiesbaden, Germany|Novartis Investigative Site, Athens, Greece|Novartis Investigative Site, Pokfulam, Hong Kong|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Dublin, Ireland|Novartis Investigative Site, Ancona, Italy|Novartis Investigative Site, Bari, Italy|Novartis Investigative Site, Bologna, Italy|Novartis Investigative Site, Bolzano, Italy|Novartis Investigative Site, Brescia, Italy|Novartis Investigative Site, Cagliari, Italy|Novartis Investigative Site, Campobasso, Italy|Novartis Investigative Site, Catania, Italy|Novartis Investigative Site, Catanzaro, Italy|Novartis Investigative Site, Ferrara, Italy|Novartis Investigative Site, Firenze, Italy|Novartis Investigative Site, Genova, Italy|Novartis Investigative Site, Milano, Italy|Novartis Investigative Site, Monza, Italy|Novartis Investigative Site, Napoli, Italy|Novartis Investigative Site, Novara, Italy|Novartis Investigative Site, Nuoro, Italy|Novartis Investigative Site, Orbassano, Italy|Novartis Investigative Site, Padova, Italy|Novartis Investigative Site, Palermo, Italy|Novartis Investigative Site, Pavia, Italy|Novartis Investigative Site, Perugia, Italy|Novartis Investigative Site, Pesaro, Italy|Novartis Investigative Site, Pescara, Italy|Novartis Investigative Site, Pisa, Italy|Novartis Investigative Site, Reggio Calabria, Italy|Novartis Investigative Site, Reggio Emilia, Italy|Novartis Investigative Site, Rionero in Vulture, Italy|Novartis Investigative Site, Roma, Italy|Novartis Investigative Site, Ronciglione, Italy|Novartis Investigative Site, San Giovanni Rotundo, Italy|Novartis Investigative Site, Siena, Italy|Novartis Investigative Site, Tarante, Italy|Novartis Investigative Site, Torino, Italy|Novartis Investigative Site, Udine, Italy|Novartis Investigative Site, Via Pansini, Italy|Novartis Investigative Site, Daegu, Korea, Republic of|Novartis Investigative Site, Deajeon, Korea, Republic of|Novartis Investigative Site, Jeollanam-do, Korea, Republic of|Novartis Investigative Site, Pusan, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, Republic of|Novartis Investigative Site, Beirut, Lebanon|Novartis Investigative Site, Georgetown, Penang, Malaysia|Novartis Investigative Site, Kuala Lumpur, Malaysia|Novartis Investigative Site, Pulau Pinang, Malaysia|Novartis Investigative Site, Subang Jaya, Selangor, Malaysia|Novartis Investigative Site, Mexico D.F., Mexico|Novartis Investigative Site, Amsterdam, Netherlands|Novartis Investigative Site, Enschede, Netherlands|Novartis Investigative Site, Leiden, Netherlands|Novartis Investigative Site, Maastricht, Netherlands|Novartis Investigative Site, Rotterdam, Netherlands|Novartis Investigative Site, Oslo, Norway|Novartis Investigative Site, Gdansk, Poland|Novartis Investigative Site, Krakow, Poland|Novartis Investigative Site, Poznan, Poland|Novartis Investigative Site, Szczecin, Poland|Novartis Investigative Site, Warszawa, Poland|Novartis Investigative Site, Chelyabinsk, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Novosibirsk, Russian Federation|Novartis Investigative Site, Saint-Petersburg, Russian Federation|Novartis Investigative Site, Samara, Russian Federation|Novartis Investigative Site, Ufa, Russian Federation|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Bratislava, Slovakia|Novartis Investigative Site, Kosice, Slovakia|Novartis Investigative Site, Cape Town, South Africa|Novartis Investigative Site, Johannesburg, South Africa|Novartis Investigative Site, Roodepoort, Gauteng, South Africa|Novartis Investigative Site, Baracaldo, Pais Vasco, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Cataluna, Spain|Novartis Investigative Site, Granada, Andalucia, Spain|Novartis Investigative Site, Las Palmas de Gran Canaria, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Malaga, Spain|Novartis Investigative Site, Murcia, Spain|Novartis Investigative Site, Salamanca, Castilla y Leon, Spain|Novartis Investigative Site, San Sabastian, Pais Vasco, Spain|Novartis Investigative Site, Santiago de Compostela, Spain|Novartis Investigative Site, Valencia, Spain|Novartis Investigative Site, Zaragoza, Spain|Novartis Investigative Site, Goteborg, Sweden|Novartis Investigative Site, Linkoping, Sweden|Novartis Investigative Site, Lund, Sweden|Novartis Investigative Site, Stockholm, Sweden|Novartis Investigative Site, Uppsala, Sweden|Novartis Investigative Site, Basel, Switzerland|Novartis Investigative Site, Bern, Switzerland|Novartis Investigative Site, Lausanne, Switzerland|Novartis Investigative Site, Zurich, Switzerland|Novartis Investigative Site, Chiayi, Taiwan|Novartis Investigative Site, Kaohsiung, Taiwan|Novartis Investigative Site, Taichung, Taiwan|Novartis Investigative Site, Tainan, Taiwan|Novartis Investigative Site, Taipei, Taiwan|Novartis Investigative Site, Bangkok, Thailand|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Istanbul, Turkey|Novartis Investigative Site, Malatya, Turkey|Novartis Investigative Site, Samsun, Turkey|Novartis Investigative Site, Cambridge, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, Liverpool, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Manchester, United Kingdom|Novartis Investigative Site, Nottingham, United Kingdom Less << | |
NCT04498871 | Hypereosinophilic Syndrome (HE... More >>S) Less << | NO_LONGER_AVAILABLE | - | - | |
NCT00718562 | Gastrointestinal Stromal Tumor... More >>s Less << | PHASE2 | COMPLETED | 2025-07-13 | Novartis Investigative Site, N... More >>agoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Kashiwa, Chiba, 277-8577, Japan|Novartis Investigative Site, Fukuoka-city, Fukuoka, 812-8582, Japan|Novartis Investigative Site, Sapporo-city, Hokkaido, 060-8648, Japan|Novartis Investigative Site, Niigata-city, Niigata, 951-8520, Japan|Novartis Investigative Site, Suita-city, Osaka, 565-0871, Japan|Novartis Investigative Site, Sunto-gun, Shizuoka, 411-8777, Japan|Novartis Investigative Site, Chuo-ku, Tokyo, 104-0045, Japan Less << |
NCT03942094 | Chronic Myeloid Leukemia, Chro... More >>nic Phase|Nilotinib Less << | PHASE3 | UNKNOWN | 2023-12-01 | Shenzhen Second People's Hospi... More >>tal, Shenzhen, Guangdong, 518035, China Less << |
NCT00264160 | Leukemia, Myeloid, Chronic | PHASE2|PHASE3 | COMPLETED | 2025-08-09 | Novartis Investigative Site, H... More >>aifa, Israel|Novartis Investigative Site, Jerusalem, Israel|Novartis Investigative Site, Petach Tikva, Israel|Novartis Investigative Site, Tel Hashomer, Israel Less << |
NCT00109707 | Chronic Myelogenous Leukemia|A... More >>cute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|Hypereosinophilic Syndrome|Systemic Mastocytosis Less << | PHASE1|PHASE2 | COMPLETED | 2025-09-12 | City of Hope National Medical ... More >>Center, Duarte, California, 91010, United States|Stanford University Medical Center, Stanford, California, 94305-5750, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt, Tampa, Florida, 33612, United States|University of Chicago Medical Center Dept. of U. of Chicago Hosp(3), Chicago, Illinois, 60637, United States|University of Illinois at Chicago Divisionof Hematology/Oncology, Chicago, Illinois, United States|Indiana Blood and Marrow Institute Dept of Indiana Blood&Mar (2), Beech Grove, Indiana, 46107, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States|Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Div.of Hematologic Malignancie, Baltimore, Maryland, 21231, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Health System Clinical Trials Office, Ann Arbor, Michigan, 48109, United States|Wayne State University, Detroit, Michigan, 48201, United States|Mayo Clinic - Rochester, Rochester, Minnesota, 55905, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Roswell Park Cancer Institute Rosewell SC, Buffalo, New York, 14263, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10017, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States|Oregon Health Sciences University, Portland, Oregon, 97239, United States|The Jones Clinic, Germantown, Tennessee, 38138, United States|Vanderbilt University Medical Center, Clinical Trials Center Investigational Drug Services, Nashville, Tennessee, 37212, United States|MD Anderson Cancer Center/University of Texas, Houston, Texas, 77030, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Novartis Investigative Site, St. Leonards, New South Wales, 2065, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Prahran, Victoria, 3181, Australia|Novartis Investigative Site, Wien, A-1090, Austria|Novartis Investigative Site, Bruxelles, 1000, Belgium|Novartis Investigative Site, Haine-saint-Paul, 7100, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Yvoir, 5530, Belgium|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E3, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Montreal, Quebec, H3A 1A1, Canada|Novartis Investigative Site, Vejle, DK-7100, Denmark|Novartis Investigative Site, HUS Helsinki, FIN-00029, Finland|Novartis Investigative Site, Bordeaux Cedex, 33076, France|Novartis Investigative Site, Créteil, 94010, France|Novartis Investigative Site, Dijon, 21034, France|Novartis Investigative Site, Lille, 59037, France|Novartis Investigative Site, Limoges cedex, 87042, France|Novartis Investigative Site, Lyon, 69437, France|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Poitiers, 86021, France|Novartis Investigative Site, Rennes, 35019, France|Novartis Investigative Site, Vandoeuvre les Nancy, 54511, France|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Frankfurt/M, 60590, Germany|Novartis Investigative Site, Hamburg, 20246, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Mannheim, 68169, Germany|Novartis Investigative Site, Muenchen, 81675, Germany|Novartis Investigative Site, Pokfulam, Hong Kong|Novartis Investigative Site, Bergamo, BG, 24128, Italy|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Monza, MB, 20900, Italy|Novartis Investigative Site, Milano, MI, 20162, Italy|Novartis Investigative Site, Pescara, PE, 65124, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Reggio Calabria, RC, 89124, Italy|Novartis Investigative Site, Roma, RM, 00144, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Roma, RM, 00168, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Hwasun-gun, Jeollanam-do, 519-809, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 05505, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 137-701, Korea, Republic of|Novartis Investigative Site, Taegu, 700 - 721, Korea, Republic of|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Rotterdam, Netherlands|Novartis Investigative Site, Grafton, Auckland, New Zealand|Novartis Investigative Site, Oslo, NO-0310, Norway|Novartis Investigative Site, Katowice, 40-635, Poland|Novartis Investigative Site, Lodz, 90-153, Poland|Novartis Investigative Site, Warszawa, 02-097, Poland|Novartis Investigative Site, Warszawa, 02-776, Poland|Novartis Investigative Site, Wroclaw, 50-367, Poland|Novartis Investigative Site, Singapore, 169608, Singapore|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, 08907, Spain|Novartis Investigative Site, G?teborg, SE-413 45, Sweden|Novartis Investigative Site, Link?ping, SE-581 85, Sweden|Novartis Investigative Site, Lund, SE-221 85, Sweden|Novartis Investigative Site, Uppsala, SE-751 85, Sweden|Novartis Investigative Site, Basel, 4031, Switzerland|Novartis Investigative Site, Genève, 1211, Switzerland|Novartis Investigative Site, Niaosong Township, 83301, Taiwan|Novartis Investigative Site, Birmingham, B15 2TH, United Kingdom|Novartis Investigative Site, Cambridge, CB2 2QQ, United Kingdom|Novartis Investigative Site, Glasgow - Scotland, G12 OYN, United Kingdom|Novartis Investigative Site, Leeds, LS9 7TF, United Kingdom|Novartis Investigative Site, Liverpool, L7 8XP, United Kingdom|Novartis Investigative Site, London, SE5 9RS, United Kingdom|Novartis Investigative Site, London, W12 0NN, United Kingdom|Novartis Investigative Site, Newcastle upon Tyne, NE1 4LP, United Kingdom Less << |
NCT04518644 | Chronic Myelogenous Leukemia (... More >>CML) Less << | NO_LONGER_AVAILABLE | - | - | |
NCT00905593 | Chronic Myeloid Leukemia | APPROVED_FOR_MARKETING | - | Novartis Investigative Site, G... More >>uadalajara, Jalisco, Mexico|Novartis Investigative Site, Mexico City, Mexico Less << | |
NCT00905398 | Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma|Acute Lymphoblastic Leukemia Less << | PHASE1|PHASE2 | TERMINATED | 2025-07-15 | - |
NCT00481052 | Chronic Myeloid Leukemia | PHASE2 | COMPLETED | 2018-04-30 | Dipartimento Area Medica P.O.,... More >> Ascoli Piceno, 63100, Italy|Unità Operativa Ematologica - Università degli Studi di Bari, Bari, 70124, Italy|Ospedali Riuniti, Bergamo, 24100, Italy|stituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy|Sezione di Ematologia e Trapianti Spedali Civili, Brescia, 21125, Italy|Azienda Spedali Civili, Brescia, 25100, Italy|ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy|Ospedale Ferrarotto, Catania, 95124, Italy|Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, 88100, Italy|Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna, Ferrara, Italy|Azienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Napoli, Italy|Ospedale S. Luigi Gonzaga, Orbassano, 10043, Italy|La Maddalena Casa di Cura di Alta Specialità Dipartimento Oncologico di III Livello, Palermo, Italy|Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza, Piacenza, Italy|Ospedale S.Maria delle Croci, Ravenna, 48100, Italy|Calabria Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|Università La Cattolica del Sacro Cuore, Roma, 00168, Italy|Complesso Ospedaliero S. Giovanni Addolorata, Roma, 00184, Italy|Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy|U.O. Ematologia, Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy|Policlinico Universitario - Clinica Ematologia, Udine, 33100, Italy|Policlinico G.B. Rossi, Verona, 37134, Italy Less << |
NCT01201538 | Growing Vestibular Schwannomas | PHASE2 | TERMINATED | 2025-10-13 | Toronto Western Hospital, Toro... More >>nto, Ontario, m5t 2s8, Canada|University Health Network, Toronto, Ontario, m5t 2s8, Canada Less << |
NCT01274351 | Chronic Myelogenous Leukemia | PHASE2 | COMPLETED | 2019-08-01 | Novartis Investigative Site, E... More >>skisehir, Meselik, 26480, Turkey|Novartis Investigative Site, Istanbul, TUR, 34098, Turkey|Novartis Investigative Site, Adana, 01330, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Bursa, 16059, Turkey|Novartis Investigative Site, Diyarbakir, 21000, Turkey|Novartis Investigative Site, Gaziantep, 27310, Turkey|Novartis Investigative Site, Istanbul, 34093, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Izmir, 35340, Turkey|Novartis Investigative Site, Okmeydani, 34370, Turkey|Novartis Investigative Site, Talas / Kayseri, 38039, Turkey|Novartis Investigative Site, Trabzon, 61080, Turkey Less << |
NCT00384228 | Chronic Myelogenous Leukemia|A... More >>cute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Less << | PHASE1|PHASE2 | COMPLETED | - | Novartis Investigative Site, T... More >>okyo, Japan Less << |
NCT01227577 | Chronic Myelogenous Leukemia i... More >>n Chronic Phase Less << | PHASE4 | COMPLETED | 2025-11-14 | Pacific Cancer Medical Center,... More >> Inc., Anaheim, California, 92801, United States|Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer, Burbank, California, 91505-6866, United States|Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord, California, 94520, United States|St. Jude Heritage Medical Group Virginia Crosson Cancer Center, Yorba Linda, California, 92886, United States|Sarah Cannon Research Institute SCRI, Jacksonville, Florida, 32256, United States|Advanced Medical Specialties, Miami, Florida, 33176, United States|Pasco Hernando Oncology, New Port Richey, Florida, 34652, United States|Georgia Regents University MedCollege of GA Cancer Ctr 2, Augusta, Georgia, 30912, United States|Stroger Cook County Hospital Division of Hematology & Onc, Chicago, Illinois, 60612, United States|Louis A. Weiss Memorial Hospital, Chicago, Illinois, 60640, United States|Indiana Blood and Marrow Institute, Beach Grove, Indiana, 46107, United States|Cancer Center of Kansas, Witchita, Kansas, 67214-3728, United States|LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center(3), New Orleans, Louisiana, 70115, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|St. Louis University Cancer Center, St. Louis, Missouri, 63110, United States|University of Nebraska Medical Center University of Nebraska Med Ctr, Omaha, Nebraska, 68198, United States|Hackensack University Medical Center Dept.of HackensackUniv.MedCtr., Hackensack, New Jersey, 07601, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|University of Rochester Medical Ct James P Wilmot Cancer Ctr, Rochester, New York, 14642, United States|Duke University Medical Center Duke University Med Ctr, Durham, North Carolina, 27710, United States|Oregon Health & Science University, Portland, Oregon, 97201, United States|Cancer Centers of the Carolinas Cancer Center, Greenville, South Carolina, 29605, United States|Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, 37404, United States|The Jones Clinic, Germantown, Tennessee, 38138, United States|Tennessee Oncology Sarah Cannon Research Inst., Nashville, Tennessee, 37203, United States|Baylor Research Institute Baylor Research Institute (17), Dallas, Texas, 75204, United States|Oncology Consultants Oncology Consultants, P.A., Houston, Texas, 77024, United States|Millennium Oncology, Houston, Texas, 77090, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|Providence Regional Cancer Partnership, Everett, Washington, 98201, United States Less << |
NCT03932669 | Ataxia, Cerebellar|Ataxia, Pro... More >>gressive Less << | PHASE2 | COMPLETED | 2020-08-13 | Seoul National University Hosp... More >>ital, Seoul, 03080, Korea, Republic of Less << |
NCT00786812 | Chronic Myeloid Leukemia | PHASE4 | COMPLETED | 2025-01-12 | Novartis Investigative Site, B... More >>elo Horizonte, MG, 30130-100, Brazil|Novartis Investigative Site, Curitiba, PR, 80060-900, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20230-130, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90035-903, Brazil|Novartis Investigative Site, Campinas, SP, 13083-970, Brazil|Novartis Investigative Site, Jaú, SP, 17210-080, Brazil|Novartis Investigative Site, Ribeirao Preto, SP, 14048-900, Brazil|Novartis Investigative Site, S?o Paulo, SP, 01401-901, Brazil|Novartis Investigative Site, S?o Paulo, SP, 05403-000, Brazil Less << |
NCT04559555 | Acute Lymphoblastic Leukemia (... More >>ALL) Less << | NO_LONGER_AVAILABLE | - | - | |
NCT02389920 | Leukemia, Chronic Myeloid | PHASE4 | UNKNOWN | 2025-12-18 | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.89mL 0.38mL 0.19mL |
9.44mL 1.89mL 0.94mL |
18.89mL 3.78mL 1.89mL |